EXPRESSION OF SUBSTANCE P IN BRAINSTEMS OF VICTIMS OF SUDDEN UNEXPLAINED PERINATAL DEATH by R.M. Mehboob
1 
 
EXPRESSION OF SUBSTANCE P IN BRAINSTEMS OF VICTIMS OF SUDDEN 
UNEXPLAINED PERINATAL DEATH 
 
 
 
 
 
A THESIS 
 
Submitted by 
 
 
RIFFAT MEHBOOB 
 
For the award of the Degree of 
 
 
DOCTOR OF PHILOSOPHY 
 
International PhD Program 
in Pathology 
 
 
 
 
 
 
LINO ROSSI RESEARCH CENTER 
FOR THE STUDY AND PREVENTION OF SUDDEN PERINATAL DEATH AND SIDS 
DEPARTMENT OF SURGICAL, RECONSTRUCTIVE AND DIAGNOSTIC SCIENCES,  
UNIVERSITY OF MILAN, ITALY 
 
 
JANUARY 2011 
2 
 
Declaration 
 
  
"I hereby declare that this submission is my own work and that, to the best of my knowledge and 
belief, it contains no material previously published or written by another person nor material 
which has been accepted for the award of any other degree or diploma of the university or other 
institute of higher learning, except where due acknowledgment has been made in the text.  
 
 
 
 
 
 
Place:        Signature  
 
 
Date          Name:        
 
 
Reg.No  
 
 
 
 
 
 
 
 
 
 
3 
 
Certificate 
 
 
This is to certify that the thesis entitled: “EXPRESSION OF SUBSTANCE P IN 
BRAINSTEMS OF VICTIMS OF SUDDEN UNEXPLAINED PERINATAL DEATH”, 
submitted by Ms……RIFFAT MEHBOOB…… to Department of Surgical, Reconstructive and 
Diagnostic Sciences, Lino Rossi Research Center, University of Milan, for the award of the 
degree of Doctor of Philosophy is a bona fide record of the research work carried out by her 
under my supervision and guidance. The content of the thesis, in full or parts have not been 
submitted to any other Institute or University for the award of any other degree or diploma. 
 
Signed by Research Supervisor(s) with name(s) and date 
 
Place 
 
Date 
 
Signature of Head of the Department  
 
(Office seal)  
 
 
 
 
 
 
 
 
4 
 
Acknowledgements 
"God has two dwellings; one in heaven and the other in a meek and thankful heart". 
“All our dreams can come true if we have the courage to pursue them”(Walt Disney). 
First of all, I am thankful to God (Almighty Allah) for giving me this wonderful opportunity to 
learn and become part of such a good research facility. My sincerest gratitude to my supervisor Prof. 
Luigi Matturri, for selecting me for this research work, giving chance to grow scientifically and 
professionally. I am very grateful for his advice, encouragement and mentoring throughout the time I 
spent in his lab and it has been a privilege to work under his supervision. I am very grateful to Prof Anna 
Maria Lavezzi for encouragement, guidance and support from the initial to the final level of my 
dissertation which enabled me to develop an understanding of the subject. Without her help this work 
would not have been possible. 
The writing of this dissertation has been a milestone in my academic life and could not have been 
possible without support of teachers, colleagues, friends and family. A big thanks for our lab technician 
Graziella Alfonsi for granting her friendly contribution in histological preparation of brainstems and 
moral support. I would also like to thank my colleague Melissa Corna for her support during the work. 
Special thanks to Adnan Syed for his valuable advice and discussion on the computational and 
bioinformatics aspect of my studies.  
I am grateful to my parents Rehana and Mehboob Hasnain for giving me freedom, opportunity to 
pursue my own interests, raising me with a love of science and blessing me with an environment in which 
I could pursue my dreams. I would also thank my brothers Khurram and Zeeshan for their support and 
encouragement.  Pick and drop provided by Zeeshan during college and university days, even in odd 
timings or late working hours of lab will always be appreciated. I can never forget the cherished 
memories of my late brother Noman and prayers of late grandmother for my success. This work is 
dedicated to my loving parents who mean world to me and this work would not have been possible 
without their unconditional love. 
I would also thank to University of Milan for financial support during this research work of 
sudden infant deaths. I owe my deepest gratitude to the deceased fetuses, infants and SIDS victims who 
were part of this study. Lastly, I offer my regards and blessings to all of those who supported me in any 
respect during the completion of the project. 
Thankyou 
Riffat Mehboob 
University of Milan 
January 2011 
5 
 
Table of Contents 
ACKNOWLEDGEMENTS .......................................................................................................... 4 
LIST OF FIGURES ...................................................................................................................... 8 
LIST OF TABLES ........................................................................................................................ 9 
ABSTRACT ................................................................................................................................. 10 
CHAPTER I ................................................................................................................................ 11 
1. AN OVERVIEW OF SUDDEN UNEXPLAINED PERINATAL AND INFANT 
DEATH  ........................................................................................................................................ 11 
1.1. Historical Perspective .............................................................................................................................. 12 
1.2 Pathophysiology and Triple Risk Model ................................................................................................... 14 
1.3 RISK FACTORS INVOLVED IN SIDS .................................................................. 14 
1.3.1 Infant factors ........................................................................................................................................... 15 
1.3.1.1 Race/ethnicity ....................................................................................................................................... 15 
1.3.1.2 Prematurity ........................................................................................................................................... 16 
1.3.1.3 Infant Botulism (Intoxication) ............................................................................................................... 16 
1.3.1.4 Male sex ................................................................................................................................................ 16 
1.3.1.5 Heart related abnormalities .................................................................................................................. 16 
1.3.1.6 Neuropathology .................................................................................................................................... 17 
1.3.1.7 Cardiorespiratory control ...................................................................................................................... 18 
1.3.1.8 Infection ................................................................................................................................................ 19 
1.3.1.9 Deformational plagiocephaly ................................................................................................................ 19 
1.3.2 Maternal factors ...................................................................................................................................... 19 
1.3.2.1 Pregnancy related factors ..................................................................................................................... 20 
1.3.2.2 Maternal smoking ................................................................................................................................. 20 
1.3.3 Environmental or Postnatal factors ......................................................................................................... 21 
1.3.3.1 Prone sleeping position ......................................................................................................................... 21 
1.3.3.2 Day, Time, Month and Place ................................................................................................................. 21 
1.3.3.3 Geographical link ................................................................................................................................... 22 
1.3.3.4 Socio-economic status/ Poverty............................................................................................................ 22 
1.3.3.5 Softbedding and overheating/overclothing .......................................................................................... 22 
6 
 
1.3.3.6 Lack of breast feeding ........................................................................................................................... 23 
1.3.3.7 Bedsharing/cosleeping .......................................................................................................................... 23 
1.3.3.8 Use of pacifiers ...................................................................................................................................... 23 
1.3.4 Genetic studies in SIDS .......................................................................................................................... 24 
CHAPTER II .............................................................................................................................. 25 
2 TACHYKININS ........................................................................................................... 25 
2.1 Tachykinin Genes ..................................................................................................................................... 27 
2.2 Tachykinin receptors ............................................................................................................................. 30 
2.3 Substance P ............................................................................................................................................. 32 
2.3.1 Role of Substance P in Brain ................................................................................................................... 33 
2.3.2 Role of Substance P in regulation of Respiratory rhythm ......................................................................... 36 
2.3.3 Role of Substance P in different systems .................................................................................................. 38 
2.4 Trigeminal System .................................................................................................................................. 42 
2.4.1 Trigeminal Ganglion ................................................................................................................................... 42 
2.4.2 Mesencephalic Trigeminal Nucleus ........................................................................................................... 46 
CHAPTER III .............................................................................................................................. 48 
AIM OF STUDY.......................................................................................................................... 48 
3 MATERIAL AND METHODS ................................................................................... 49 
3.1 Protocol for the examination of Brainstem .............................................................................................. 50 
3.2 Preparation of solutions .......................................................................................................................... 51 
3.2.1 Preparation of Phosphate buffered saline (PBS) ....................................................................................... 51 
3.2.2 Preparation of Citrate buffer ..................................................................................................................... 51 
3.2.3 3% Hydrogen peroxide solution ................................................................................................................ 51 
3.2.4 Blocking Serum (Normal Serum) ............................................................................................................... 51 
3.3 Primary Antibody .................................................................................................................................... 51 
3.4 Secondary Antibody ................................................................................................................................ 51 
3.5 Dyes, Substrates, Pretreatment, Embedding Media, Counterstains and Mountant ................................. 51 
3.5.1 Embedding Media ..................................................................................................................................... 51 
3.5.2 STA-ON ...................................................................................................................................................... 52 
7 
 
3.5.3 ABC Reagent .............................................................................................................................................. 52 
3.5.4 Horseradish Peroxidase Substrates ........................................................................................................... 52 
3.5.5 Dyes and Counterstains ............................................................................................................................. 52 
3.5.6 Mountant ................................................................................................................................................... 52 
3.6 Equipment ............................................................................................................................................... 52 
3.7 Processing of Brainstem Manually ........................................................................................................... 53 
3.8 Embedding of Brainstem Tissue Sample .................................................................................................. 53 
3.9 Protocol for Histology of Brainstem ......................................................................................................... 53 
3.10 Hematoxylin-Eosin Staining ..................................................................................................................... 54 
3.11 Preparation of Slides for immunohistochemistry ..................................................................................... 54 
3.12 Substance P Immunohistochemistry (IHC) ............................................................................................... 55 
3.13 Statistical analysis ................................................................................................................................... 55 
3.14 Data mining for TAC1 ............................................................................................................................... 55 
3.14.1 Genomic duplicability of TAC1 gene ..................................................................................................... 56 
3.14.2 Phylogenetic analysis.of TAC1 gene ...................................................................................................... 56 
3.14.3 Network properties of TAC1 gene ......................................................................................................... 56 
3.14.4 Generation of Amino acid Sequence Logos .......................................................................................... 56 
CHAPTER IV .............................................................................................................................. 57 
4 RESULTS ...................................................................................................................... 57 
4.1 Developmental cytoarchitecture of the human spinal TrN in control fetal and infant deaths .................. 58 
4.2 Neuropathology of the spinal TrN in unexplained perinatal death and SIDS ............................................ 60 
4.3 Relation with smoking exposure .............................................................................................................. 61 
4.4 Brainstem pathological results overall ..................................................................................................... 61 
4.5 COMPUTATIONAL ANALYSIS .................................................................................................................... 64 
5 DISCUSSION ................................................................................................................ 68 
7 REFERENCES ............................................................................................................. 73 
8 
 
8 ABBREVIATIONS ....................................................................................................... 95 
9 CURRICULUM VITAE .............................................................................................. 97 
 
List of Figures 
Figure 1: Triple risk model showing epidemiological and genetic factors affecting the 
cardiorespiratory control and leading to SIDS .............................................................................. 15 
Figure 2: Schematic representation of a transverse section of the medulla oblongata (at the obex 
level) showing the localization of the principal nuclei ................................................................. 20 
Figure 3: Structure of TAC1 gene  ............................................................................................... 28 
Figure 4: Transmembrane topology prediction of NK-1R by using ConPred II ......................... 30 
Figure 5: Tachykinin receptor genes ............................................................................................ 31 
Figure 6: Distribution of SP in human brain ................................................................................ 34 
Figure 7: Distribution of SP in different systems of body ........................................................... 40 
Figure 8: Processing of nociceptive stimulus within brain .......................................................... 43 
Figure 9: Trigeminal nerve and its branches ................................................................................ 44 
Figure 10: Graphical representation of Trigeminal nerve nucleus (TrN) .................................... 46 
Figure 11: Brainstem showing trigeminal nucleus ...................................................................... 47 
Figure 12: Sampling of the brainstem from brain ventral (left) and dorsal (right) surface.  
Structure of brainstem [Modified from L. Testut, “Anatomia Umana”, Unione Tipografico-
Editrice Torinese, Torino, 1923] ................................................................................................... 50 
Figure 13: Diagram of the histological sections corresponding to the three fragments obtained 
from the sampling procedures of brainstem for the anatomo-pathologic examination, indicating 
the main nuclei and structures to be examined. ............................................................................ 54 
Figure 14: Photomicrograph of a transverse histological hemisection of medulla oblongata 
(dorsolateral portion) of a fetus of control group (died at 18th gestational weeks), showing in the 
boxed area (magnified in B) the trigeminal nucleus with poor number of positive fibres of the 
tract. ............................................................................................................................................... 57 
9 
 
Figure 15: SP-IR of fibers in trigeminal nucleus, with interstitial island of immunonegative 
neurons, in an infant died at 4 months of life of bronchopneumonia............................................ 58 
Figure 16: Magnocellular core (see arrow) of spinal trigeminal nucleus in infant of contol group 
aged 2 months at A: lower (20X) and B: higher (40X) magnification of large neurons.. ............ 59 
Figure 17: SP-immunopositivity of the raphe obscurus nucleus and of the reticular formation in 
control infant aged 3 months. ........................................................................................................ 60 
Figure 18: Dense plexus of SP-IR fibers in the trigeminal nucleus area in a SIUD victim aged 32 
gestational weeks........................................................................................................................... 61 
Figure 19: Poor immunopositivity of fibers in the trigeminal nucleus area in SIDS victim 3 
months old. .................................................................................................................................... 62 
Figure 20: Hypoplasia of the trigeminal nucleus with depletion of immunopositive fibers and 
rare interstitial neurons. ................................................................................................................. 62 
Figure 21: BLAT results of human TAC1 gene........................................................................... 64 
Figure 22: Protein-protein interaction of TAC1 gene by using STRING 8.3 .............................. 65 
Figure 23: Phylogenetic tree of TAC1 gene by using MAFFT online version 6.0 ...................... 66 
Figure 24: Amino acid sequence conservation in the vertebrate prepro- TAC1 gene from 26 
species. .......................................................................................................................................... 67 
List of Tables 
 
Table 1: Amino acid sequences of Tachykinins ........................................................................... 26 
Table 2: Tachykinin genes ........................................................................................................... 29 
Table 3: Tachykinin receptors ...................................................................................................... 32 
Table 4: Overall neuropathological brainstem findings in 20 SIDS, 16 SIUD and 20 controls .. 63 
 
 
10 
 
Abstract 
 
Sudden perinatal death including SIDS is a rare but lethal syndrome and there is no 
symptom of this disorder until the fatal outcome has occurred. Epidemiological, genetic, 
molecular and pathological studies conducted so far give us some possible explanations about it 
but are inadequate to explain it completely. Brainstem etiology is a mostly accepted hypothesis 
to induce sudden perinatal death. We investigated the immunohistochemical expression of 
substance P (SP) in the brainstems of 56 subjects aged from 17 gestational weeks to 10 postnatal 
months, died of unknown (sudden unexplained perinatal deaths and SIDS) and known causes 
(controls). The goals of this study were to obtain basic information about the expression of the 
SP during the first phases of human nervous system development; to evaluate whether there are 
altered manifestations of this neuromodulator in victims of sudden death; to verify the 
correlation with maternal cigarette smoking and to see the evolutionary aspects of SP gene 
(TAC1) through computational analysis.  
Immunohistochemistry demonstrated SP-immunoreactivity in correspondence of the 
caudal trigeminal nucleus area, with progressive increase in density of positive fibers of the 
corresponding tract from fetal life to first postnatal months. So, we first delineated the structure 
of the human trigeminal nucleus, so far little investigated, and provided essential data on its 
morphologic and functional development. Nevertheless, a negativity or low SP-positivity of the 
tract fibres was detectable in a wide subset of SIDS and, conversely, high SP-expression in a 
wide subset of sudden fetal deaths. Therefore we postulate, on the basis of these results, the 
functional importance of the SP in the early phases of central nervous system development and 
in the regulation of autonomic functions.  
Besides, the observation of a significant correlation between sudden unexplained death, 
altered SP staining and maternal smoking, prompted us to suppose a close relation between 
smoking absorption in utero and decrease of the functional activity of the trigeminal nucleus, 
leading to sudden death during pregnancy and in the first months of life. Computational analysis 
suggests that SP encoding gene (TAC1) is a singleton, appeared in vertebrates and is more prone 
to induce neuropathologies along with its interactors, if mutated or functionally altered, as it is 
located mostly in brain 
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CHAPTER I 
1. An overview of sudden unexplained perinatal and infant death 
Perinatal mortality includes fetal (still-births or fetal death), neonatal and post-neonatal 
infant mortality (sudden infant death syndrome or SIDS). According to WHO, “stillbirth is birth 
of a deceased baby weighing more than 500 grams and born after 22nd gestational weeks” (WHO 
2005). Fetal death or stillbirth is divided into antenatal (antepartum) and intranatal (intrapartum 
or during birth) death (Lavezzi et al. 2004). Sudden Infant Death Syndrome  (SIDS), also called 
as crib or cot death, has been defined as, “the sudden death of an infant younger than 1 year that 
remains unexplained after thorough case investigation, including performance of a complete 
autopsy, examination of the death scene, and review of the clinical history (Willinger et al. 
1991)”. It remains a diagnosis of exclusion (Molz 1997) and  is the most common and leading 
cause of infant mortality. Its incidence in United States is 0.57 deaths per 1000 live births 
annually (Willinger et al. 1991).  
Every year more than 133 million babies are born and 3 million are stillborns (one quarter of 
these are intrapartum deaths), 2.8 million die during first week of life and approximately one 
million die during the next three weeks. Incidence of these deaths is more in developing 
countries (WHO 2007). Still births account for 70% of perinatal deaths and one third of these 
deaths are unexplained. Incidence of stillbirth is 10 times higher as compared to SIDS 
(http://www.stillbirthalliance.org).  
When we look at the characteristic features of SIDS, we find that a normally healthy 
infant with an age range of 1-6 months dies suddenly and unexpectedly due to unknown causes. 
There is no inheritance pattern of any disease and autopsy procedures also fail to identify a lethal 
cause. There is more risk for an infant who is male, premature and has symptoms of respiratory 
infections. Victims are mostly  found dead while asleep, usually belongs to economically poor 
family and incidence is high in winter (Froggatt and James 1973). Anatomo-pathological studies 
reveal oedema in the lungs (Kerenyi and Fekete 1969), petechiae on infant's heart, lungs, and 
thymus (Ferris et al. 1973;  Anderson, Bouton et al. 1974) brain-stem gliosis (Kinney etal. 1983), 
upper respiratory tract infection (Froggatt and James 1973), neuropathological (Lavezzi et al. 
2010)  and conduction system abnormalities (Ottaviani and Bergui 2009). 
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1.1. Historical Perspective 
Although the term “Sudden Infant Death Syndrome” is established in 1969 but the 
documentary record of SIDS dates back to Biblical times and it is written in Holy Bible, where 
the ‘Judgment of Solomon’ is described, “and this woman’s  child died because she overlaid it” 
(1st Kings, chapter 3, verse 19). Roman Catholic Church announced punishment for killing the 
infants by overlaying, although it was considered a small sin at that time (Guntheroth 1989).  
Record of SIDS is also found from Euripides (a Greek Tragedian of classical Athens 480 
BC-406 BC), “what greater pain can mortals bear than this; to see their children die before their 
eyes?” Diodurus Siculus (a Greek historian who lived in 1st century BC) reported that Eygptian 
mothers were blamed for overlaying their babies. Demon god Larbatu was held responsible for 
SIDS in Babylonia (Russell-Jones 1985). 
Medieval book by Welsh priest Giraldus Cambrensis (Irish musician born in 12th century) 
also gives records about SIDS. According to a German Placard cited by Sudhoff in 13th century 
(Dresden Catalogue 6375), mothers were not allowed to take infants under 3 years into their beds 
at night (Russell-Jones 1985). Throughout 14th century overlaying of baby was considered a 
forgivable sin.  In sixteenth century it was considered a major sin. During the 17th century, SIDS 
was attributed to mechanical suffocation and certain measures were taken such as arcuccio (arch 
made of wood and iron that was placed over the infant’s head during sleep). This practice of 
using arch continued till the end of 19th century.  
During 18th and 19th century, mothers were usually blamed for overlaying their babies 
while drunk. SIDS as a medical issue gained more attention in 19th century. In 1892, 
Templeman, a Scottish pathologist, analysed 258 cases of sudden death in infants, in the town of 
Dundee and attributed these deaths to ‘suffocation’ by ‘overlaying’. His main focus was on 
carelessness, drunkenness of the caretaker and overcrowding in small place due to low 
socioeconomic status (Templeman 1892). A British Physician, Anthony Leared MD (1862) and  
Brendon Curgenven (1871) attributed SIDS to mechanical suffocation (due to bedsheets, under 
the breast, overclothing), overlaying and carelessness of the caretaker (Russell-Jones 1985).  
Since 17th century till the early and mid 20th century, overlying or suffocation was 
considered as the only cause of SIDS. Paltauf (1889) proposed theory of  “Status lymphaticus” 
which states that hypertrophy of thymus gland is the cause of sudden death of an infant but it was 
rejected by Hammar (Hammar 1906). In 1918, Pritchard (Pritchard 1918) suggested that 
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hypertrophy of suprarenals instead of thymus is responsible for SIDS but this theory also didn’t 
get much approval. Werne and Garrow in 1940 for the first time proposed that inflammatory 
responses may be the cause of death in infants and not only the suffocation (Werne 1942).  
White suggested a combination of factors namely infection, congenital abnormality, 
suffocation and aspiration of regurgitated food as the causes of SIDS (White 1948). By the end 
of 1950s, the theory of infection of upper airway as cause of SIDS started to get more attention 
(Crowley and Emery 1956). Parish in 1960 proposed that sudden death in infancy may be due to 
allergic reaction to foreign protein in the form of cow’s milk (Parish et al. 1960). Three 
hypothesis were given in late 1950s and 1960s, regarding SIDS: an overwhelming infection, 
suffocation from soft bedding and an anaphylactic type of reaction resulting from inhalation of 
cow's milk by a milk-sensitized child (Carpenter and Shaddick 1965; Sutton and Emery 1966; 
Parish et al. 1960). 
Morgan proposed the following possible causes of SIDS: infection, pneumonia, allergic 
shock, laryngeal spasm, inhalation of vomitus, overlaying, thymus gland pressure, cardiac 
arrhythmias, inherited cardiac conduction anomalies and  adrenal insufficiency (Morgan 1969). 
Froggatt suggested three factors responsible for SIDS: asphyxia from laryngospasm or nasal 
obstruction, cardiac conduction disturbance, and some hypersensitivity or aberrant 
immunological reaction (Froggatt et al. 1971). Money proposed vitamin E and selenium 
deficiency as a possible cause of SIDS. He pointed that human milk has more selenium and 
Vitamin E as compared to cow’s milk and bottle fed infants suffer its deficiency and have more 
risk of getting hit by SIDS (Money 1971).  Rhead rejected this hypothesis (Rhead et al. 1973). 
Frais suggested hypokalemia as a cause of SIDS (Frais 1972).  
 Myeloid leukaemia was reported by Dr. Alice Stewart as a numerically important cause 
of cot deaths (Stewart 1975) but it was also not widely accepted. Apnea theory was the dominant 
hypothesis during 1970s and 1980s (Mitchell 2009). According to Tonkin (Tonkin 1975) and 
Tapp (Tapp et al. 1975): in addition to apnea (Steinschneider 1972), nasal obstruction or 
laryngeal spasm  (Shaw 1970), inflammation of the respiratory tract is also involved in sudden 
infant deaths due to suspension in respiration. Although surgical repair of tetralogy of fallot 
results in an improvement in the duration and quality of life for most patients, late sudden deaths 
are known to occur (Sondheimer et al. 1976). 
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 Abnormalities of cardiac conduction system and cardiorespiratory control centers got 
attention at the end of 1960s and start of 1970s when James first pointed out the involvement of 
conducting tissue of the heart in SIDS (James 1968). Now it is known that dysfunctions, 
maldevelopment of cardiac structures, mutations, polymorphisms in genes encoding receptors 
and subunits for cardiac channels (Killen et al. 2010; Liu et al. 2010; Plant et al. 2006) are 
involved in SIDS.  
In 1984, a disorder of fatty acid oxidation—medium chain acyl CoA dehydrogenase 
(MCAD) deficiency—was the first example of an inherited metabolic disorder to be recognised 
as the cause of death in an infant who had originally been classified as having died of SIDS 
(Howat et al. 1985). At the end of 1970s, there was an increase in attention to brainstem 
hypothesis of  SIDS (Naeye 1976). Irrespective of the triggering factor, neural control of cardiac 
and/or respiratory system was ultimately found to be the underlying mechanism (Becker et al. 
1993).  
1.2 Pathophysiology and Triple Risk Model 
The first grouping of SIDS risk factors was done by Wedgwood in 1972. He proposed a 
“triple risk hypothesis”, consisting of general vulnerability, age-specific risks, and precipitating 
factors (Wedgwood 1972). The "fatal triangle" presented by Rognum and Saugstad (Rognum 
and Saugstad 1993) had the same groupings like previous triple risk hypothesis, but he added 
mucosal immunity under a vulnerable developmental stage of the baby. The Triple risk 
hypothesis of Filiano and Kinney (Filiano and Kinney 1994) is famous and widely accepted in 
which they have included prenatal injury of the brainstem as a risk factor. The National Institute 
of Child Health and Development SIDS Strategic Plan 2000, states that "SIDS is a 
developmental disorder. Its origins are during fetal development." All of these hypothesis are 
same and the only difference is the prenatal origin (Guntheroth and Spiers 2002). Filiano and 
Kinney’s model suggests that an interaction of genetic, environmental and biological factors is 
required for SIDS to occur and these factors include (Fig. 1), “a vulnerable infant who possesses 
intrinsic abnormalities in cardiorespiratory control, a critical period of development of 
homeostatic control mechanisms, and exogenous stressors.” 
1.3 Risk factors involved in SIDS 
Theories on the possible causes of SIDS are more than hundered. It is widely accepted 
that SIDS is a combination of multifactors that occur during the period of increased vulnerability 
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and may cause the fatal outcome in some infants (Otto-Buczkowska 2002). "Bergman (1970) 
also argued that SIDS did not depend on any, "single characteristic that ordains an infant for 
death," but on an interaction of risk factors with variable probabilities (Bergman 1970). 
Pathophysiology of SIDS remains unexplained (Hunt and Brouillette 1987). Following are some 
factors (Fig. 1) known to be involved in the etiology of SIDS. 
 
Figure 1: Triple risk model showing epidemiological and genetic factors affecting the 
cardiorespiratory control and leading to SIDS 
1.3.1 Infant factors 
1.3.1.1 Race/ethnicity 
In US, there was a high incidence of SIDS among African-Americans than for white or 
oriental. Inappropriate prenatal care, co-sleeping or poor living conditions may be the underlying 
mechanisms of high prevalence of SIDS in African-Americans (Unger et al. 2003; Borhani et al. 
1973; Kitsantas and Gaffney 2010). Different ethnic groups were observed to have different risk 
profiles for adverse pregnancy outcomes in Canada (Luo et al. 2004). 
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1.3.1.2 Prematurity 
Low birth weight, prematurity and low APGAR (Appearance, Pulse, Grimace, Activity 
and Respiration) scores are mostly associated with infant mortality (Kapoor et al. 1994; Cheron 
et al. 1993; Borhani  et al. 1973). Many structures of the heart and brain that play vital role in 
sleep/arousal or cardiorespiratory control are not fully developed in premature infants and may 
lead to the death of infant (Lavezzi et al. 2010). 
1.3.1.3 Infant Botulism (Intoxication) 
A neurotoxin botulinum produced by Clostridium botulinum blocks the 
neurotransmission in the cholinergic synapses (Fischer et al. 2004) and cause weakness of 
muscles, paralysis and has been implicated in SIDS also. Infant botulism and SIDS is associated 
in 20% of the cases (Bartram and Singer 2004). Honey and raw vegetables are a source of 
Clostridium botulinum, but as the infant has no vegetable intake, so the only source can be 
honey. Honey should not be given to infant less than 6 months to prevent botulism. 
1.3.1.4 Male sex 
Male infants dying of SIDS are in consistently 50% in excess per 1000 live births of each 
sex but the reason of this high male prevalence is not well understood. The only explanation 
available for the excess of male SIDS victims as compared to the females suggests the dominant 
X-linkage hypothesis for SIDS (Mage and Donner 2004). 
1.3.1.5 Heart related abnormalities 
Thomas James in 1968 firstly emphasized the role of cardiac conduction system as a 
contributing factor to SIDS. He investigated conduction systems of 56 infants, out of which 40 
were SIDS cases. He found partial “resorptive degeneration” of the A-V node and left portion of 
His bundle in all of the SIDS cases (James 1968). Investigations of SIDS cases revealed heart 
related anomalies or dysfuncions such as myocarditis (Carturan et al. 2007), cardiac arrhythmias, 
cadiacmyopathy, hypoxia-related changes, disturbances of the rhythmogenic function and 
cardiac dysregulation as the most frequent finding. Disturbances of cardiac rhythmogenic 
function due to LQTS were among the most speculative (Bajanowski et al. 2003). Cardiac 
arrhythmias accounted for 5-10%  (Thach 2005) and myocarditis was diagnosed in 25% of SIDS 
cases (Madea 2009). 
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Conduction system anomalies found in SIDS are resorptive degeneration, fetal 
dispersion, hypoplasia of cardiac conduction system, splitting of the atrioventricular node or of 
the His bundle and a Zahn node, accessory atrioventricular pathways (mostly Mahaim fibres), 
cartilaginous hypermetaplasia and junctional islands (Matturri et al. 2008; Ottaviani and Matturri 
2008; Ottaviani and Bergui 2009; Lavezzi et al. 2005; Ottaviani 2010). 
1.3.1.6 Neuropathology 
Role of brainstem in pathophysiology of SIDS got attention in 1976 when Naeye’s 
reported astrogliosis in 50% of SIDS victims (Naeye 1976). Some anatomical structures and 
areas of central nervous system (CNS) are involved in the regulation of autonomic function and 
respiration during a critical developmental stage and anomalies in any of these structures can 
induce SIDS, still birth or sudden intrauterine death (SIUD) (Duncan et al. 2010; Guntheroth and 
Spiers 2002). Due to these abnormalities, an infant becomes unable to respond to any stressor 
during sleep (e.g. hypoxia, hypercarbia) and dies suddenly during a vulnerable period of 
postnatal life (Kinney et al. 2009). In order to understand the mechanisms of sudden perinatal 
death, we should first know about neuropathology along with epidemiological and genetic 
factors. 
According to Kinney, brain research in SIDS follows three directions:  “analysis to 
determine a primary (neural) cause of death (developmental anomaly), analysis to uncover 
secondary changes that points to the primary cause, either within the brain or in other organ 
systems (oxygen deficiency events), and analysis to determine the age of onset of the chain of 
events prenatally and/or postnatally that results in sudden death in the vulnerable postnatal 
period” (Kinney 2009). Insufficient oxygen supply, immunological reactions and apoptotic 
neurodegeneration are the underlying mechanisms for neuropathological lesions in perinatal 
stage leading to sudden death. Examinations of brains of sudden perinatal death victims gives us 
an insight into the neuropathological events that can cause brain lesions in liveborn as well as 
stillborn infants and that cause brain disorders and SIDS in liveborn infants (Grafe and Kinney 
2002; Sparks and Hunsaker 2002).  
Morphology and/or  functional alterations of one or more of the brainstem structures that 
regulate sleep-awake cycle through cardiorespiratory control centers, or failure to arouse or both 
may be involved in the pathology of SIDS (Sparks and Hunsaker 2002). Lavezzi and Matturri 
reported developmental alterations (hypoplasia, neuronal immaturity, and gliosis) of the arcuate 
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nucleus (Arc) (Matturri et al. 2002) (Fig. 2), Inferior olivary nucleus (ION) (Fig. 2), Dentate 
nucleus (DN) (Lavezzi et al. 2007), pre-Botzinger complex (Lavezzi and Matturri 2008) (Fig. 2), 
triangle of Guillain and Mollaret (G-Mt) a neuronal brainstem/cerebellum network (from the 
dentate nucleus to red nucleus and inferior olivary nucleus), the hypoglossal nucleus (HGN) 
(Fig. 2), intermediolateral nucleus (ILN) (Lavezzi et al. 2010), vagal dorsal motor nucleus 
(Lavezzi et al. 2003), locus coeruleus (LC) (Lavezzi et al. 2005) and the parabrachial Kolliker-
Fuse complex in the pons (Lavezzi et al. 2004) of stillborns, unexplained perinatal and SIDS 
victims. Neuropathological changes provides a link between antenatal factors such as smoking 
and SIDS (Lavezzi et al. 2010). Recently, Lavezzi et al 2010, reported a possible role of 
damaged ependyma, the lining providing a protective barrier and filtration system separating 
brain parenchyma from cerebrospinal fluid, in SIDS because ependyma is the first to get affected 
before other autonomic nervous system centers, by the noxious agents entering to the fetus from 
mother (Lavezzi et al. 2010). 
1.3.1.7 Cardiorespiratory control 
All the factors whether maternal, infant, environmental or genetic, interfere with the 
cardiorespiratory control (Fig. 1) leading to final common pathway (death). Mechanisms 
underlying SIDS appear to originate in fetal period of development resulting in neural damage 
and affect breathing or blood pressure during sleep later on (Harper et al. 2000). Critical periods 
in the human development is from 2-4 months of gestation and at this stage, fetus is more 
vulnerable and at high risk to environmental, genetic and biochemical factors. These traumatic 
factors may alter the normal development of the respiratory control centers related to spinal 
constriction and compression following birth trauma and may contribute to SIDS (Banks et al. 
1987).  
Anomalies and immaturity of neuroregulator neuronal systems such as monoaminergic 
and peptidergic systems in medulla oblongata (Kopp et al. 1994), catecholaminergic systems 
(Kopp et al. 1992) in vegetal central areas of brainstem, muscarinic (Kinney et al. 1995) and 
serotonergic systems (Kinney et al. 2001) in brainstem have been observed and provide a 
possible mechanism of death in SIDS. Serotonin provides a key role in mediating protective 
responses to homeostatic stressors via medullary circuits (Kinney et al. 2009). Changes in 
dendritic synapses, delayed myelinisation (O'Brien 1993), some neurotransmitters, some 
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peptides, their enzymes and receptors may adversely affect cardiorespiratory  swallowing control 
systems chemoreception (Harper 2000). 
Vulnerable infants are born with respiratory centre immaturity which in combination with 
other problems such as illness, head colds, exposure to cold, air or smoke, may result in cessation 
of breathing (Nattie and Kinney 2002). More emphasis should be given to the understanding of 
mechanisms of breathing control in neonate and the maturation of cardiorespiratory control 
during infancy (Ozawa and Takashima 2002). Defects in brainstem neural circuits involved in 
cardiorespiratory control may be one of the leading cause of SIDS (Kinney and Filiano 1988). 
1.3.1.8 Infection 
Templeman in 1892 analysed 258 SIDS cases and found 74% of the cases with upper 
respiratory tract infections (Templeman 1892). Adelson and Kinney (Adelson and Kinney 1956) 
also noticed 55% of SIDS cases they investigated with upper airway infections within one week 
before death. The authors concluded that “no single bacterial organism or group of organisms 
was cultured from any site with a degree of consistency sufficient to indicate that it had probable 
etiological significance”.Viral infection is not the only cause of SIDS but an association of upper 
respiratory tract infection and SIDS was also noted by enhanced detection rate of viruses in SIDS 
cases as compared to the controls (Fleming 1992). But no single bacterial or viral agent has been 
causally linked to SIDS (Williams et al. 1984).  
1.3.1.9 Deformational plagiocephaly 
Approximately half of the infants, who sleep in supine position, get affected by 
deformational plagiocephaly (flattening of the occiput). This problem has increased since the 
back to sleep campaign started. In order to prevent the negative effects of this problem e.g skull 
deformities, infants should be given “tummy time,” in which they should spend maximum time 
on their stomach instead of backs while being awake (Persing et al. 2003). 
1.3.2 Maternal factors 
SIDS incidence is normally high in infants whose mothers are less than twenty years 
(Borhani et al. 1973) or over 35 years of age (http://www.stillbirthalliance.org), obese, have 
visited the prenatal care unit after the forth gestational months (Gunther 1975), use illegal drugs 
such as methadone  (Burns et al. 2010) and alcohol (Phillips et al. 2010) during pregnancy as 
compared to the control group.  
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1.3.2.1 Pregnancy related factors   
 Maternal health during pregnancy is an important factor and mothers with shortened 
gestational age (Cheron et al. 1993), primiparity, high parity, multiple pregnancies (Gunther 
1975) or anemia are more likely to have hypoxia and brainstem injury and could have 
endangered pregnancy outcomes (Froggatt et al. 1971; Guntheroth and Spiers 2002). 
 
Figure 2: Schematic representation of a transverse section of the medulla oblongata (at the obex 
level) showing the localization of the principal nuclei 
In many cases of SIDS, mothers had previous history of sexually transmitted diseases, 
urinary tract infections (Stewart et al. 1995), abnormal and complicated pregnancy, suffered 
from influenza, had received anaesthezia at the time of delivery and had Vasa praevia (a rare 
obstretic complication that causes antepartum haemmorhage) during pregnancies (Pallewela 
1974). Mode of delivery of infant is also a crucial factor and many of the SIDS infants were 
found to have non vertex or breech presentation (Kapoor et al. 1994). An increase in the rate of 
SIDS was observed for labor more than 16 hours (Buck et al. 1991). 
1.3.2.2 Maternal smoking 
Maternal smoking also contributes to the pathology of SIDS (Krous 1984) and victims of 
SIDS show a higher incidence of respiratory control abnormalities including central apneas, 
delayed arousal responses and diminished ventillatory chemoreflexes. Nicotine is most probably 
a causal link between maternal smoking and sudden death (Eugenin et al. 2008). Several 
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experiments have revealed the fact that exposure to nicotine prenatally alters the central 
chemosensitivity and changes the muscarinic receptor to nicotinic. It also alters the systems of 
serotonin, noradrenaline, GABA (Gamma amino butyric acid), glycine and glutamine. Maternal 
tobacco smoking alters the respiratory control of perinatal infant by two main mechanisms: 
reorganization of Neurotransmitter (NT) systems and remodeling of neural circuits. These 
changes make breathing more vulnerable to fail in early postnatal life, which could be related to 
pathogenesis of SIDS (Campos et al. 2009). Intra-uterine growth retardation (IUGR) that is a 
major risk factor for SIDS is caused by maternal smoking. Carbon monoxide and nicotine are 
among the largely investigated components of cigarette smoke. They can directly affect the 
development of fetal brain or indirectly by inducing oxgen insufficiency (Gressens et al. 2003). 
In utero fetal exposure to tobacco smoke adversely affects growth and accounts for about one-
third of perinatal deaths (Mitchell and Milerad 2006). 
1.3.3 Environmental or Postnatal factors 
1.3.3.1 Prone sleeping position 
SIDS is typically associated with sleep (Kinney et al. 2009). Firstly, the association 
between supine sleeping position and SIDS was observed in 1965 but the recommendations to 
support it were issued in 1990s (Mitchell et al. 1991). Prone sleeping position has been known as 
a cause of SIDS since then. After the introduction of  “Back to Sleep Campaign,” there has been 
a dramatic reduction in SIDS (Blatt et al. 1999). Sleeping position is most modifiable risk factor 
(Adams et al. 2009). Several reports from well developed countries like Norway and Britain 
show that by putting the babies at their back for sleep can reduce the risk by half (Haaland and 
Thoresen 1992; Willinger et al. 1994). An infant in supine sleeping position is at reduced risk  
for reflex apena during upper airway infection leading to SIDS as compared to the infant 
sleeping prone (Crooks et al. 2004). 
1.3.3.2 Day, Time, Month and Place 
 Prenatal deaths are mostly observed during the weekends as compared to the working 
days. More deaths were reported on saturday night (Peterson 1966), sunday night (Froggatt et al. 
1971) and monday morning (Glasgow et al. 2006). Mothers are usually drunk during weekends 
and overlay babies. Most of the infant mortalities occur during midnight when the child is asleep. 
He is mostly found dead in the morning (Wedgwood 1972). A study showed that 50% of the 
infants died from midnight to 8am, 36% between 8am and 4pm, and 14% between 4pm and 
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midnight (Froggatt et al. 1971; Hodges 1972). Templeman found that 62% of the victims died 
during October to March (Templeman 1892). More prevalence was found between December to 
March in a Canadian study (Kraus et al. 1967) and many other studies also reported that SIDS is 
common in colder months of the year (Fedrick 1973). In one study, over 70% of infants were 
found dead at home, 6.8 % on way to hospital and 22-3% at hospital (Fedrick 1973). This also 
indicates delay in taking the infant to the hospital and lack of health care facilities may be the 
possible causes, as most deaths were at home. 
1.3.3.3 Geographical link  
Incidence of SIDS varies with geographical location. Sudden unexplained perinatal 
deaths were more prevalent in the higher latitudes (Mitchell 2009). Sweden has the lowest rate of 
SIDS which is reported as being as low as 0.6 SIDS deaths for 1000 live births. In comparison 
Ontario, Canada had a reported 3 SIDS deaths per 1000 live births.  The actual mechanism is not 
known but improved living standard may be a possible cause of low incidence of perinatal deaths 
in Canada and Scandanavia. 
1.3.3.4 Socio-economic status/ Poverty 
A significant association between adverse social circumstances and SIDS has been 
observed (Spencer and Logan 2004).  A population based chohort study was conducted in US 
during two periods, 1989-1991 and 1996-1998 using US linked birth/Infant death data sets. 
Social class of mother was measured by mother’s education level. Results indicated that SIDS 
rate was associated with lower social class (Pickett et al. 2005). Templeman in 1892 pointed out 
that death incidence was more in areas with poor housing conditions and he concluded that these 
deaths are due to suffocation and overlying because many family members slept in small place to 
keep themselves warm (Templeman 1892). Unemployment, low social class, car ownership, 
rented accommodation and overcrowding are five census-based indicators of Deprivation Index. 
Many infants born to unmarried (illegitimate) ,divorced or widow mothers are more prone to die 
of SIDS due to poor health care facilities and low income (Gunther 1975). 
1.3.3.5 Softbedding and overheating/overclothing 
Werne and Garrow proposed that overlying may be responsible for SIDS and for a long 
time suffocation by covering the baby in bedsheets was considered as the cause (Werne and 
Garrow 1947). Overheating is a possible factor to have an effect on the sudden deaths (Gotestam 
1991; Peduto et al. 1994). Correlation between the use of soft bedding and SIDS has been 
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noticed in victims in different Nordic and other countries too (Gotestam 1991). In two 
independent studies, it was found that infants who died of SIDS had more clothes on; heads were 
covered with bed clothes and blankets covering them. Possible mechanism is that overheating 
may interfere with the respiratory control (Haaland and Thoresen 1992). Prevalence of 
headcovering in final sleep was observed in 24.6% as compared to 3.2% among controls. 
Covering of head  is a main modifiable risk factor related to SIDS (Blair et al. 2008). 
1.3.3.6 Lack of breast feeding 
Infants who are not breastfed are at more risk for SIDS than breastfed infants. It is an 
important modifiable risk factor to reduce SIDS (Stuebe 2009). Recommended time period for 
breastfeeding by American Academy of Pediatrics (AAP) (Gartner et al. 2005) and the American 
Academy of Family Physicians (AAFP) (Vennemann et al. 2009) is first six months exclusively 
and two years by the World Health Organization (WHO) (Stuebe 2009). 
1.3.3.7 Bedsharing/cosleeping 
Co-sleeping is a controversial matter among health professionals and parents. Increased 
rate of breastfeeding (Haycock and Greenough 2007) and parent child bond (Horsley et al. 2007) 
are among the positive affects of bedsharing while it can also cause sudden death of infant due to 
overlaying. The AAP (American Association of Pediatrics) discouraged co-sleeping of parents 
and infant as well as infant  with an older child in 2005 by stating that it is the cause of SIDS in 
United States in one half of the SIDS cases (2005).   
1.3.3.8 Use of pacifiers 
A great reduction in the rate of SIDS was observed  after using pacifiers, dummies or 
soothers during the final sleep (Sexton and Natale 2009). Mechanism underlying this observation 
is not known. Use of soothers may also lower the other risk factors related to SIDS such as prone 
sleeping position. It was evidenced in various studies that infants who were sleeping  prone 
without pacifiers had greater risk of sudden death (Li et al. 2006). Some researchers oppose the 
use of pacifiers by stating that it may increase the risk of SIDS by decreasing the duration of 
breastfeeding but this issue remains controversial (Mitchell et al. 2006). According to the most 
accepted concept, the use of pacifiers should be suggested in infants from one to 6 months of age 
but not after 6 months to prevent otitis media (Marter and Agruss 2007; Sexton and Natale 
2009). 
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1.3.4 Genetic studies in SIDS 
Candidate genes of SIDS are divided into 5 categories by Weese-Mayer (Fig. 1), as 
follows: genes for ion channel proteins based on electrocardiographic evidence of prolonged QT 
intervals in SIDS victims, gene for serotonin transporter based on decreased serotonergic 
receptor binding in brainstems of SIDS victims, genes pertinent to the early embryology of the 
autonomic nervous system (ANS) (and with a link to the 5-HT system) based on reports of ANS 
dysregulation in SIDS victims, genes for nicotine metabolizing enzymes, genes regulating 
inflammation, energy production, hypoglycemia, and thermal regulation based on reports of 
postnatal infection, low birth weight, and/or overheating in SIDS victims.  More genetic 
polymorphisms in serotonin transporter (5-HTT) are found to have a correlation with defected 
neural pathways components of serotonin binding (Weese-Mayer et al. 2007).  
Genetic polymorphisms of voltage-gated sodium channel cardiac cells and type V alpha 
(SCN5A), designated S1103Y in Black American infants is associated with an increased risk of 
SIDS. Both wild and mutant SCN5A channels are functional under normal invitro conditions but 
exposure to low intracellular pH produced altered gain of function delayed reopenings of 
S1103Y channels, a behavior usually related to cardiac arrhythmias. Lower pH can cause 
conditions like respiratory acidosis which is a known factor to increase SIDS rate (Makielski 
2006). Genetic modifications of cardiac channels, give new observations after thorough 
molecular autopsy of potassium channel genes linked to  long QT syndrome in SIDS (Tester and 
Ackerman 2009). Potentially lethal cardiac channelopathies are responsible for about 10% of 
SIDS cases and most of these victims have genetically modified cardiac sodium channel due to 
beta subunit mutations. Na (V) beta subunits have a role in cardiac arrhythmias and the 4 genes 
(SCN-1B to 4B) encoding them are candidate genes for SIDS pathogenesis responsible for 1% of 
SIDS cases (Tan et al. 2010). Dominant X-Linked inheritance need further study in future to 
investigate the candidate genes for high SIDS prevalence in male infants (Mage and Donner 
2004). 
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CHAPTER II 
2 Tachykinins 
Tachykinin (TK) family of neuropeptides is one of the largest peptide families that are 
described in the animals. Till now, more than forty tachykinin (TK) peptides have been identified 
in the animal kingdom including invertebrates, protochordates and vertebrates (Severini et al. 
2002). Substance P like immunoreactivity (SP-LI) was localized in nervous systems of Hydra 
(Pierobon et al. 1989), locust (Benedeczky et al. 1982), cockroach (Verhaert and De Loof 1985),  
lobster (Mancillas et al. 1981), blowfly (Lundquist et al. 1994) and several other invertebrates 
but all of these were not authentic tachykinins while TKs identified in octopods E. moschata and 
Eledone aldovrandi and mosquito Aedes aegypti (Champagne and Ribeiro 1994) containing 
eledoisin, sialokinins I and II, are authentic because they have signature terminal pentapeptide 
sequence F(X)GLMNH2 (Erspamer and Anastasi 1962) and have more resemblance to the 
mammalian TKs and also bind to the same receptors (Severini et al. 2002). 
 A significantly less SP-LI is found in Amphioxus lanceolatus (Lembeck et al. 1985)  and 
ascidian Ciona intestinalis (Protochordate) but they are not like mammalian TK peptides 
(Severini et al. 2002). Among submammalian vertebrates; reptiles, amphibians, fish, and agnatha 
contain authentic NKA and NKB peptides. First submammalian TK, physalaemin, was identified 
in 1964 by Erspamer from the skin of frog (Erspamer et al. 1964) and two more TKs, 
scyliorhinins I and II were isolated from dogfish intestine 22 years later (Conlon et al. 1986). By 
the end of 20th century, 24 TKs were identified from these vertebrates, 12 from the brain and 12 
from digestice tract (Severini et al. 2002). 
Substance P (SP), Neurokinin A (NKA) and Neurokinin B (NKB) are the best known 
members of this family (Page 2004) in mammals. This family of neuropeptides is enlarged by the 
later addition of newly discovered Endokinins (EK), Hemokinins (HK) (Page 2004), Virokinins 
(VK) (Zimmer et al. 2003; Nelson and Bost 2004) and Chromosome 14 tachykinin like peptide-1 
(C14TKL-1) (Nelson and Bost 2004). Neuropeptide K (NPK) and  Neuropeptide gamma (NPg) 
(Kage et al. 1988) are N-terminally extended forms of NKA. Three gene related peptides, EK-2 
(Page 2004) in rabbit, EKC and EKD in human are identified (Page et al. 2003). Virokinin (VK) 
is a converted derivative of the bovine respiratory syncytial virus (BRSV) fusion protein 
(Zimmer et al. 2003).   
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TKs are evolutionary conserved excitatory neuropeptides or peptide hormones 
characterised by a common, specific C-terminal signature motif: FXGLMNH2. X (Fig.24, Table 
1) is an aromatic or aliphatic amino acid. This hydrophobic and amidated sequence is important 
for the specific responses and generation of signal pathways. It is also necessary for TK receptor 
binding. 
 
Tachykinins Amino acid sequence 
SP RPKPQQFFGLM-NH2 
NKA HKTDSFVGLM-NH2 
NPγ DAGHGQISHKRHKTDSFVGLM-NH2 
NPK 
 
DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-
NH2 
NKB DMHDFFVGLM-NH2 
HK- 1 (Mouse) RSRTRQFYGLM-NH2 
HK-1 (human) TGKASQFFGLM-NH2 
EKA/EKB (human) TGKASQFFGLM-NH2 
C14TKL-1(human) 
RHRTPMFYGLM-NH2 
 
VK 
 
GIPELIHYTRNSTKKFYGLM-NH2 
TK gene-related 
peptides 
 
EKC (human) KKAYQLEHTFQGLL-NH2 
EKD (human) VGAYQLEHTFQGLL-NH2 
 
Table 1: Amino acid sequences of Tachykinins 
Tachykinins (TKs) are widely distributed throughout the mammalian body in both the 
central nervous system (CNS) and peripheral nervous system (PNS) (Howard et al. 2006). TKs 
are ubiquitous and are identified in many species of vertebrates and invertebrates (Holmgren and 
Jensen 2001).Capsaicin-sensitive sensory nerves have been considered as the principal source of 
TKs at the peripheral level (Patacchini et al. 1998). Previously, they were considered to be 
synthezied and released from CNS neurons, capsaicin sensitive primary afferent neurons and 
capsaisin-insensitive intrinsic neurons of the gastrointestinal tract (Maggi 1995; Holzer and 
Holzer-Petsche 1997) but now it is known after several studies, that TKs are also found in non-
neuronal and non-innervated tissues (Patak et al. 2003) such as bone marrow stem cells 
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(BMSCs), mature blood cells (Zhang et al. 2006), epithelial cells, immune cells (Weinstock et al. 
1988), endothelial muscle cells, macrophages, neutrophils, tumor cells, vascular endothelial cells 
(Linnik and Moskowitz 1989), inflammatory cells (Maggi 1997), somatotroph and thyrotroph 
cell populations of the anterior pituitary gland (Brown et al. 1991), in blood circulation (Pernow 
1983) and even in placenta which is a tissue completely devoid of nerves (Page et al. 2000). 
SP is mostly found in limbic regions and brainstem nuclei such as the dorsal raphe 
nucleus (DRN) (Froger et al. 2001) and it is synthesized in B cells of the dorsal root ganglion 
(DRG) cells (Liu et al. 2007), neuronal and glial cells of human nervous system (Lazarczyk et al. 
2007). The presence of SP in rat cerebellum is 3 times more than NKA and NKB (Otsuka and 
Yoshioka 1993). NKB is confined mostly to the CNS (Goubillon et al. 2000). Hemokinin-1 (HK-
1) and endokinins are expressed in non-neuronal cells (Patak et al. 2003). Chromosone 14 
tachykinin like peptide 1 (C14TKL-1) mRNA has been detected in many human central and 
peripheral tissues (Groneberg et al. 2006). 
Tachykinins have been associated with many physiological processes in the 
cardiovascular, nervous, respiratory and immune systems (Pernow 1983). In addition to 
mediating certain physiological functions, SP and its receptors are also involved in some 
pathophysiological conditions (Liu et al. 2007). TKs are synthesised in neuronal and glial cells of 
the human central and peripheral nervous system (Lazarczyk et al. 2007). TKs are linked to 
neurological conditions, such as depression (Sergeyev et al. 2005), anxiety (Ebner and 
Singewald 2006), Parkinsonian syndrome, Parkinson’s disease (Barker 1989) and Alzheimer’s 
disease. The TKs have also been implicated in traumatic brain injury (TBI) (Zacest et al. 2010), 
ischemic stroke and epileptic seizures (Ko et al. 1991). At the level of CNS, SP has been found 
to be involved in  conditions such as nausea, vomiting and pain (Harrison and Geppetti 2001). 
2.1 Tachykinin Genes 
Three genes namely TAC1,TAC3 and TAC4 (Table 3), belonging to the family of 
preprotachykinins (PPTs), encode TKs (Nowicki et al. 2007). Previously these genes were called 
PPT-A, PPT-B and PPT-C respectively (Nawa et al. 1983). PPTs are larger precursor molecules 
that produce many peptides after differential RNA splicing. TAC1 and TAC3 PPTs are two 
homologous genes (Nawa et al. 1983; Kotani et al. 1986). TAC4 was discovered in 2000 by 
Zhang (Zhang et al. 2000). Mammalian substance P is derived from the preprotachykinin-A 
(PPT-A) or TAC1 gene (Fig. 3), which originates from a common ancestral gene by duplication 
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(Carter and Krause 1990). The tachykinin peptides substance P (SP), neurokinin A (NKA), 
neurokinin A (3-10), neuropeptide K (NPK), and neuropeptide gamma (NPγ) are produced from 
a single preprotachykinin gene PPT-A or TAC1 as a result of differential RNA splicing and 
differential posttranslational processing (Helke et al. 1990).  
PPT‐A/TAC1 comprises of seven exons, which can be alternately spliced and modified to 
form four transcripts: α, β, γ, and δ (Table 2; Fig. 3). SP is encoded by exon 3, present in each 
transcript, and NKA is encoded by exon 6, present only in transcripts β and γ (Nowicki et al. 
2007). NPK is produced by βTAC1 and γNP by γPPT-A/γTAC1 (Kawaguchi et al. 1986; Lai et 
al. 1998) by  differential processing at the N-terminal dibasic cleavage site of NKA (Krause et al. 
1989).  mRNA of each uses a different exon corresponding to the protein coding region. αPPT-A 
contains all the exons except 6 while exon 4 is missing in γPPT-A mRNA. βPPT-A mRNA 
comprise of all the 7 exons (Fig. 3) (Harrison 2001). α PPT-A mRNA expression is more 
abundant in the brain, while βPPT-A and γPPT-A mRNAs are predominately expressed in 
peripheral tissues (Kotani et al. 1986). Expression of PPT-A mRNA in nodose (Hamid et al. 
1991), trigeminal (Kiyama et al. 1988) and dorsal root ganglia (DRG) (Sternini 1991) has been 
demonstrated.                 
 
Figure 3: Structure of TAC1 gene (Harrison and Geppetti 2001) 
TAC3 or PPT-B gene also originates from the same common ancestral gene as PPT-A. 
However, the PPT-B gene encodes for NKB only (Fig. 3) (Nakanishi 1987), while TAC2 is the 
gene encoding NKB in mouse (Nelson and Bost 2004). 3 different splice variants are formed 
after proteplytic cleavage of PPT-B or TAC3 mRNA in humans, namely α, β and γTAC3 (Page 
2004). A TAC3 also comprise of 7 exons and only exon 5 encodes for NKB. TAC3 is expressed 
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in brain and peripheral tissues (Nowicki et al. 2007). TAC4 or PPT-C is relatively a new member 
of PPT family. It was identified in 2000 by Zhang (Zhang et al. 2000). It encodes for newly 
discovered TK members, Hemokinin-1 (HK-1), Endokinin A (EKA), Endokinin B (EKB), 
Endokinin C (EKC), and Endokinin D (EKD) (Pinto et al. 2004; Page 2004). TAC4 expression is 
mainly observed in peripheral tissues such as adrenal gland and placenta (Page et al. 2003).  
 
Species Gene 
Chromosomal 
location 
mRNA 
transcript 
Protein product 
Human TAC1 7q21-q22 
αTAC1 
βTAC1 
γTAC1 
δTAC1 
SP 
SP, NKA, NPγ 
SP,NKA,NPK 
SP 
Human TAC3 12q13-q21 
αTAC3 
βTAC3 
γ TAC3 
 
NKB 
NKB 
- 
Human TAC4 17q21.33 
TAC4 
αTAC4 v1 
αTAC4 v2 
βTAC4 
γ TAC4 
δ TAC4 
hHK-1,hHK-1 (4-
11) 
EKA,EKC 
EKB,EKC 
EKB,EKD 
EKB 
EKB 
Mouse TAC4 11D cM TAC4 HK-1 
Rat TAC4 10q31 cM TAC4 HK-1 
Rabbit TAC4 
- αTAC4 
βTAC4 
 
EK-1,EK-2 
EK-1 
 
Table 2: Tachykinin genes 
Preprotachykinin contains a signal peptide of 16-30 residues at N-terminal, one or several 
copies of a neuropeptide and one or more spacer parts and is formed after the translation of  
mRNA from PPT-A, PPT-B or PPT-C in nucleus. It is then transported to the endoplasmic 
reticulum where it is converted to propeptide after the removal of signal peptide. From here this 
propeptide is transported to Golgi complex where the spacer parts are clipped off to yield final 
active peptide sequence (Page et al. 2003). These active peptides are then packed into secretory 
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granules, leave the golgi apparatus and then transported through the axon to the nerve terminals 
(Holmgren and Jensen 2001). 
2.2 Tachykinin receptors 
All the physiological responses of TKs are mediated by three types of receptors namely 
Neurokinin receptor 1 (NK-1R), Neurokinin receptor 2 (NK-2R) and Neurokinin receptor 3 
(NK-3R) which binds preferentially to SP, NKA and NKB, respectively (Table 3). HK-1, EKA 
and EKB also prefer NK-1R (Zhang et al. 2000). TK receptors belong to family 1 (Rhodopsin 
like) hydrophobic 7-transmembrane (TM1-TM7) ,G protein coupled receptors (GPCRs) 
(Lavagno et al. 2001).They have 3 extracellular and 3 intracellular loops, one extracellular amino 
terminus and one intracellular carboxy terminus (Maggi 1995) (Fig. 4).These receptors are 
involved in many biological processes (Krause et al. 1992).  
Tachykinin neuropeptide, SP brings all of its cellular activities after binding to the G-
protein coupled receptor NK-1R which is located on cell surface (Helke et al. 1990). Like all TK 
receptors, SP also binds to heterotrimeric G-protein complex with a preference for Gs and Gq. 
Binding of receptor to Gs stimulates adenylyl cyclase and cyclic AMP production while binding 
 
Figure 4: Transmembrane topology prediction of NK-1R by using ConPred II 
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to Gq initiates the phosphatidyl-inositol casade (Nakanishi 1991). Upon binding of SP to NK-1R, 
a signal transduction cascade is initiated by internalization of SP-NK-1R complex (Quartara and 
Maggi 1997) resulting in activation of Phospholipase C (PLC). PLC is a second messenger and 
produces inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) (Ramkissoon et al. 2006). 
IP3 stimulates endoplasmic reticulum to release intracellular calcium and initiates many signal 
transduction cascades. DAG activates protein kinase C (PKC) (Regoli et al. 1994; Radhakrishnan 
et al. 1995). 
There are two distinct conformational isoforms of NK-1R: a full-length NK-1R (NK-
1RF) isoform and a truncated NK-1R (NK-1RT) isoform, which lacks the terminal cytoplasmic 
96-aa residues (Chernova et al. 2009). Both of these isoforms have same binding affinity for SP 
but different affinities for NKA. The NK-1R has a relatively long 5´ untranslated region 
compared to the other tachykinin receptors, which is preceded by a single TATAAA sequence 
(Hershey and Krause 1990). Three different genes termed TACR1, TACR2, and TACR3 (Table 
3; Fig. 5) encode for the NK-1R, NK-2R, and NK-3R, respectively (Pennefather et al. 2004). All 
these genes are evolutionay conserved and have same structure with five exons interrupted by 
introns in identical positions (Hershey et al. 1991; Howard et al. 2006) (Fig. 5). TM1-3 are 
encoded by exon 1, TM4 by exon 2, TM5 by exon 3 and TM6,7 by exon 4. This feature of G-
protein coupled receptors to retain the introns is very uncommon in this superfamily (Klassert et 
al. 2010). 
 
Figure 5: Tachykinin receptor genes, Modified (Howard et al. 2006) 
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TK receptors are uniquely distributed throughout the nervous system in neural as well as 
non-neural system (Patacchini and Maggi 1995). NK-1R is expressed in both central (CNS) and 
peripheral nervous system (PNS) (Tsuchida et al. 1990) while NK-2R is present mostly in PNS 
although some NK-2R immunoreactivity is also found in CNS (Naline et al. 1989; Klassert et al. 
2008). NK-3R is mostly localized to CNS and less in peripheral tissues (Massi et al. 2000). A 
single substrate type can express more than one TK receptor, so that if blockade of one receptor 
occurs, the other receptor can compensate its functions (Lecci et al. 2006) because all these TK 
receptors have high  structural specificity and homology.   
 
TK 
receptors 
Affinity for 
TKs 
Location 
Amino 
acids 
Genes 
Gene 
ID 
Chromosome 
location 
mRNA ID Protein ID 
NK-1R SP>NKA>NKB CNS/PNS 407 TACR1 6869 2p13.1-p12 
NM_001058 
 NP_001049 
NK-2R NKA>NKB>SP PNS 398 TACR2 6865 10q11-q21 
NM_001057 
 NP_001048 
NK-3R NKB>NKA>SP CNS 465 TACR3 6870 4q25 
NM_001059 
 NP_001050 
 
Table 3: Tachykinin receptors 
2.3 Substance P 
Substance P (SP) is the prototype and first discovered tachykinin. It is a neurotransmitter 
of the afferent sensory nervous system (Felderbauer et al. 2007). von Euler and Gaddum first 
identified SP as an atropine resistant factor in brain and intestine and reported that alcohol 
extracts of brain and intestine from the horse elicited a variety of strong pharmacological effects 
in animal and tissue models, most notably the contraction of smooth muscle and hypotension 
(lowered the BP by vasodilation) in rabbits (von Euler and Gaddum 1931). In 1949 Erspamer 
extracted a similarly acting substance from the salivary glands of the Mediterranean octopuses 
Eledone moschata and Eledone aldovrandi (Erspamer 1949). The structure of this non-
mammalian substance ‘Eledoisin’ was resolved in 1962 (Anastasi and Erspamer 1962). A 
substance ‘Physalaemin’ with similar properties was characterized in the following year from the 
skin of frog Physalaemus biligonigerus (Anastasi et al. 1964). Later it was confirmed that all 
these three peptide hormones are highly related members of the largest peptide family, 
Tachykinins (Severini et al. 2002).  
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‘Sialogen’, a peptide that stimulate salivation was discovered in 1967 from bovine 
hypothalamus (Leeman and Hammerschlag 1967). Lembeck and Starke (Lembeck and Starke 
1968) suggested that this peptide may be the same as SP.  In 1970, Chang isolated and purified 
this substance and called it a sialogogic peptide because it can increase secretion of saliva 
(Chang and Leeman 1970).  SP is a small peptide hormone consisting of 11 amino acids (Chang 
1971; Pernow 1983) (Table 1). It is the most abundant TK peptide, neurotransmitter, 
neuromodulator or cotransmitter in CNS of mammals (Severini et al. 2002). It has been 
implicated in various physiological and pathophysiological processes (Ebner and Singewald 
2006) and found in many central and peripheral neural pathways. SP-LI and NK1 was also 
observed in mammalian pineal gland for the first time in 2009 (Mukda et al. 2009). 
2.3.1 Role of Substance P in Brain 
SP-IR  in mammalian brain was first detected in 70s (Hokfelt et al. 1975). SP-IR has been 
demonstrated in the rhinencephalon, telencephalon, basal ganglia, hippocampus, amygdala, 
septal areas, diencephalon, hypothalamus, mesencephalon, metencephalon, pons, 
myelencephalon and spinal cord (Shults et al. 1984), as well as periaqueductal gray matter 
(Hokfelt et al. 1982), dorsal raphe nucleus (Kachidian et al. 1991), locus coeruleus (Pickel et al. 
1979), parabrachial nuclei, inferior olivary nucleus (Dean et al. 1993) and in the nucleus of the 
tractus solitarius. In lower brainstem of human fetus, an extensive network of SP-IR fibers were 
found in a number of areas (Nomura et al. 1982) (Fig. 6).   
SP is abundant in the cerebral arteries of a number of species including man, supplying 
the dura mater, arachnoid and pia mater of all brain regions (Edvinsson et al. 1983) and may be 
involved in control of cerebral blood flow in man (Mejia et al. 1988). SP-IR bodies and terminal 
networks are distributed in most areas of the brain (Hokfelt et al. 1982).  In different brain 
regions, SP frequently coexists in the same neuron with other neurokinins and with ‘classical’ 
neurotransmitters such as enkhaphalin (Pickel et al. 1979), glutamate, serotonin (Nicholas et al. 
1992), dopamine, GABA (Hokfelt et al. 1982), acetylcholine, noradrenaline, or neuropeptides 
such as hydroxytryptamine and thyrotropin releasing hormone (Dean et al. 1993).  
Some of the highest concentrations of SP in forebrain are found in areas where 
dopaminergic neurons arise or terminate (Iversen et al. 1980). It is suggested that SP mediates 
activation of dopaminergic pathway by exciting neurons of  reticulata or reticular formation 
(Collingridge and Davies 1982). Increased levels of SP within substantia nigra induces release of 
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dopamine which in turn cause SP release by positive feedback mechanism (Thornton et al. 
2010). Most if not all dendrites bearing membranous NK-1Rs appeared to be GABAergic 
(Lacoste et al. 2009). TKs activate or depress hippocampal activity by inhibiting GABAergic 
interneurons located in the CA1 region and CA1 pyramidal neurons via NK1 receptors. SP acts 
at the somatodendritic membrane of interneurons, rather than at their axon terminals (Ogier et al. 
2008). 
 
Figure 6: Distribution of SP in human brain 
SP is a nociceptive afferent neurotransmitter and most of the brain areas in which SP-LI 
is detected, have implications in modulation of stress and anxiety reactions. SP and NK-1R have 
been involved in emotion, anxiety, stress, mood, migraine, emesis, pain, and seizures (Vink and 
van den Heuvel 2010). TKs exert their effects by binding to NK receptors (Almeida et al. 2004). 
SP level is increased in specific limbic structures such as amygdalae and septum and the 
magnitude of this effect is directly related to the severity of the stressor (Ebner and Singewald 
2006). Interference with TK transmission can modulate emotional behavior and TK transmission 
is observed to be upregulated in suffering from stress-related disorders (Ebner et al. 2009). This 
undecapeptide modulates neuronal transmission of serotonin in dorsal raphe nucleus (DRN) via 
NK-1Rs and controls mood through habenular afferents (Lacoste et al. 2009). Fibers with SP and 
NKA are derived from the trigeminal ganglion (Uddman and Edvinsson 1989). SP-LI is present 
in the superficial and ventromedially located layers of nucleus caudalis. There is an abnormal 
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release of SP from all the three divisions of trigeminal nerve endings in response to nociceptive 
stimulation (Sicuteri et al. 1986). SP may have role in trigeminovascular nociceptive 
mechanisms of migraine pathophysiology (Fusayasu et al. 2007) by inducing vasodilation and 
plasma extravasation.  
SP-IR in eye is originated from trigeminal ganglion (Sasaoka et al. 1984). SP-IR nerves 
in human eye are similar to those found in other mammals. Immunoreactivity of this 
neuromodulator peptide is present in different parts of eye such as sphincter muscle (Tornqvist et 
al. 1982), cornea, retina, ciliary body (Beuerman and Stern 2005) and limbal muscles but is more 
in iridic sphincter (Tervo 1981). Neurogenic inflammation is produced in eye through the release 
of SP, in exposure to pathogens, chemical irritants and mechanical disruption. SP breaks the 
blood-tissue barrier, cause edema and release polymorphonuclear leukocytes into the tears, thus 
bringing the first line of defence to the ocular surface (Beuerman and Stern 2005).  
It was demonstrated in 2009 for the first time that SP plays an active role in memory and 
learning processes after injecting it into the ventral pallidum and is related to the globus pallidus 
(GP) and amygdaloid (AMY) (Kertes et al. 2009). GP may also be involved in reward-related 
processes. SP and its NK1 receptors play important roles in pallidal positive reinforcing 
mechanisms (Kertes et al. 2010). Activation of NK-1R in GP may be involved in positive role of 
SP in Parkinson’s disease (Chen et al. 2009). Elevated level of SP is fatal for neuronal survival 
and cause motor dysfunction, that is characteristic of Parkinson’s disease (Thornton et al. 2010). 
Co-release of SP with lactate dehydrogenase, a marker of cell death, causes neurotoxin 6-
hydroxydopamine (6-OHDA) induced cell death invitro (Thornton et al. 2010) and thus there is 
an implication of neuronal death by SP at cellular level. Neuropeptides and in particular SP is 
released after acute injury to the CNS (Vink and van den Heuvel 2010) and traumatic brain 
injury (Zacest et al. 2010) as part of neurogenic inflammatory response and plays crucial role to 
the development of morphological injury and functional deficits following traumatic brain injury 
by  modulating blood-brain barrier permeability (Donkin and Vink 2010). It induces antidromic 
vasodilation, synaptic transmission in autonomic ganglia and cerebral edema during this process. 
Elevated levels of SP under trauma or stress conditions can help central, peripheral or enteric 
nervous system to adapt to those traumatic changes and help improve survival, adaptability and 
promote recovery after injury (Hokfelt and Kuteeva 2006). Lack of production of SP may cause 
impaired neurotransmission in patients with ischemic stroke due to damage of basal ganglia and 
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decreased swallowing response, leading to aspiration pneumonia, a major cause of death in 
stroke patients (Nishiyama et al. 2010).  
2.3.2 Role of Substance P in regulation of Respiratory rhythm 
Neuromodulator Substance P produces salivation, neuronal excitation, vasodilatation, 
increased vascular permeability and contraction of smooth muscles in the respiratory tract (Koch 
et al. 1999). In humans, NK-1R is involved in causing bronchoconstriction (Naline et al. 1996). 
TKs induce neurotransmission at ganglionic and postganglionic level via NK-1R and NK-2R 
respectively (Advenier et al. 1997). NK-1Rs mediate increases in secretion of mucous glands in 
human trachea (Rogers et al. 1989). Bronchoalveolar lavage fluid (Nieber et al. 1992) and 
sputum samples (Tomaki et al. 1995) taken from asthmatics after antigen challenge show an 
increase in SP-IR. Expression of NK-1R mRNA appears to be greater in asthmatic lung tissue as 
compared to non-asthmatic tissue and chronic inflammation in asthma may result in increased 
NK-1R gene expression (Adcock et al. 1993).  
Elevated levels of SP and PPT-A mRNA were observed in the nodose ganglia of 
ovalbumin-sensitized guinea-pigs (Fischer et al. 1996) with increased neurogenic inflammation 
and bronchoconstriction produced by NK-1R (Harrison and Geppetti 2001). It suggests that SP, 
NK-1R and neurogenic inflammation is crucial in the development of airway hyper-
responsiveness (AHR) as a consequence of allergen challenge (Bertrand and Geppetti 1996) and 
NK-1R antagonists attenuated the AHR and plasma extravasation in animal models invivo 
(Harrison and Geppetti 2001). The underlying mechanism in causing AHR may be the airway 
inflammation and interaction of SP and CGRP (calcitonin gene related peptide) (Wu et al. 2007). 
Mice deficient in NK-1Rs show reduced IgG mediated lung injury and neutrophil infiltration as 
compared to the control group (Bozic et al. 1996). 
Substance P is present in bronchopulmonary C fibers (PCFs) and defend the lungs against 
injury from inhaled agents by a CNS reflex consisting of apnea, cough, bronchoconstriction, 
hypotension, bradycardia (Mutoh et al. 2000), secretion from seromucous glands, release of 
mediators (including prostaglandins and NO) from the airway epithelium (Geppetti et al. 1993) 
and bronchorelaxation (Figini et al. 1996). SP synthesis in vagal airway C fibers may be 
enhanced in pathological conditions such as allergic asthma and chronic bronchitis, and may be 
responsible for some of the associated respiratory symptoms stated above (Mutoh et al. 2000). 
SP and NKA produce bronchonconstriction and lung resistance (LR) in cynomolgus monkeys 
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(Mauser et al. 2001) and sheep (Rice et al. 2001) via NK-1 receptors and this effect is more 
pronounced when they are given by the intravenous route. 
All three tachykinin receptors NK-1R, NK-2R and NK-3R are present in the nucleus of 
the solitary tract (nTS) (Fig. 2) and are involved in the central control of respiration (Mazzone 
and Geraghty 2000). NK-1Rs are present within the respiratory medullary network and in the 
phrenic nucleus, which controls the diaphragm and mediate the respiratory responses to SP. 
Prototype TK, SP induces an increase in respiratory frequency or an increase in inspiratory 
motor output in wild-type mice, in the invitro brainstem-spinal cord preparation but not in the 
NK-1R knockout (NK-1R-/-) mice (Ptak et al. 2000).  
The study of invtro brainstem preparations revealed that neurokinin receptors (NK-Rs) 
(Table 3) have a vital role in the regulation of respiratory control and lung burst activity during 
the development of bullfrog from tadpole to adult stage (Chen and Hedrick 2008). Role of SP 
has been implicated in the development of plasticity of respiratory system and the regulation of 
respiratory rhythm. A functional SP-ergic system is necessary for the generation of sufficient 
ventillatory responses to hypoxia in newborn mice and during early maturation (Berner et al. 
2007). Under increasing hypoxia, SP manifests as natural anti-hypoxant and is not only involved 
in nociception mechanisms but also in brain adaptation to oxygen deficiency (Vlasova and 
Torshin 2001). 
SP-ergic system was found to be more active in regulating the respiratory responses 
during the early postnatal period in neonatal rat brainstem-spinal cord preparation (Shvarev and 
Lagercrantz 2006) and medullary slice preparations of newborn mice (Yasuda et al. 2001). But 
surprisingly, SP was not found to control ventillatory rhythm generation in fetal rats and it was 
hypothesized that may be SP doesnot modulate the generation of respiratory responses before 
birth and affects the phrenic motoneurons only after birth (Ptak et al. 1999).  Many changes in 
the development of brainstem nuclei occur during the first two weeks of postnatal life in rat and 
there is a decrease in the expression of SP and NK-1R expression but this situation is changed at 
postnatal day 12. Level of excitatory neurotransmitters (e.g glutamate) fall and inhibitory 
neurotransmitters (e.g GABA) and SP rise sharply. Cytochrome oxidase activity also drops in 
respiratory neurons and subunit switches occur in many receptor types. All these dramatic 
changes make the respiratory system vulnerable to any external stressor and the stressor can 
cause failure of respiratory system too. If we relate these studies in animal models to 
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physiological processes of human then we can assume that the same changes also happen in 
human and may be a possible risk factor for SIDS (Wong-Riley and Liu 2005).  
The preBötzinger complex (preBötC) (Fig. 2) is present in medulla oblongata and it has 
glutamatergic NK1R-expressing neurons (Morgado-Valle and Feldman 2004). It has a unique 
and pivotal role in the generation of respiratory rhythm patterns in neonates of mammalian and 
non-mammalian vertebrates and is sensitive to Substance P (SP) (Lavezzi and Matturri 2008; 
Kinkead 2009). SP directly acts on preBötC to modulate the respiratory activity. Any depletion 
in the level of SP within preBötC can attenuate the ventillatory rhythm generation in neonates 
(Morgado-Valle and Feldman 2004).  
2.3.3 Role of Substance P in different systems 
SP induces the release of cardiac mast cells (MC) and Angiotension II by cardiac 
inflammatory cells under the conditions of inflammation such as cardiac hypertrophy, fibrosis 
and hypertension (Levick et al. 2010). TKs such as hemokinins (HK) and SP causes the release 
of nitric oxide (NO) from coronary endothelium that relaxes the coronary vessels, decrease heart 
rate, and induces vasodilation and hypotensive responses via NK-1Rs in large arterial vessels. A 
decrease in TKs can reduce the endomyocardial NO content, which could cause reduce 
endothelium dependent vasodilation and an increased incidence of diastolic heart failure during 
aging, diabetes or posttransplantation (Paulus 2001). Alteration of vagal control of the heart by 
SP can perturb the cardiovascular regulation by increasing the sympathetic flow (Dzurik et al. 
2007).  
Substance P (SP) play a role in the immediate and late type of hypersensitivity as well as 
in neurogenic inflammation (Grzybowska-Chlebowczyk et al. 2003). Neurogenic inflammation 
provides the first line of defence to protect the tissue and contribute to the healing of wounds by 
activating the un-myelinated primary afferent sensory neurons and release of neuropeptides, 
among which SP is very important. Inflammatiory responses consist of hyperemia (Herbert and 
Holzer 2002; Birklein and Schmelz 2008) and oedema (Walsh and D 2006) accompanied by pain 
such as migraine (Fusayasu et al. 2007), asthma, fibromyalgia (Lieb et al. 2002), craniofacial 
pain, arthritis, complex regional pain syndrome (CRPS) type 2, pulmonary oedema, 
hypertension, pre-eclampsia, and  stroke (Walsh and D 2006).  Neurogenic inflammation induces 
plasma extravasation from postcapillary venules and vasodilation of arterioles (Birklein and 
Schmelz 2008). Two mechanisms interact with each other to cause neurogenic inflammation: 
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activation of the sympathetic nervous system and antidromic release of neuropeptides (e.g. 
tachykinin peptides) from sensory afferent end organs (Procacci etal., 1999). Whether the 
noxious stimulus is capsaicin, tobacco smoke, allergen, ozone, or stress, it causes substance P 
(SP), and other neuropeptides to release from the sensory nerve fibers.   
Several inflammatory skin diseases including non-atopic nummular eczema (NE), 
psoriasis (Saraceno et al. 2006; Remrod et al. 2007; El-Nour et al. 2009), ear swelling (Inagaki et 
al. 2010), scratching behavior (Inagaki et al. 2010), allergic dermatitis, pruritus, psoriasis, atopic 
dermatitis (AD) (Ohshima et al. 2010) and human malignant melanomas (Munoz et al. 2010) 
occur due to neurogenic-mediated inflammation. SP nerves are found to be increased in 
epidermis of AD and NE lesions that consequently may stimulate keratinocytes to release 
cytokines which affect various cell types by increasing vascular permeability and causing 
neurogenic inflammation. Increased vascular permeability in the skin as a result of neurogenic 
inflammation involves mast cells in addition to SP. Within the epidermis, SP immunoreactive 
nerve fibres are found in the papillary layer near the epidermal basal membrane (Schulze et al. 
1997). Although SP is found in innervated and non-innervated tissues but SP may possibly be 
more important in non-neuronal tissues in pathological conditions (Erin and Ulusoy 2009). 
Micromolar concentrations of SP are needed to evoke plasma extravasation in the skin (Petersen 
et al. 1994). Release of SP by cutaneous sensory nerves preferentially binds to NK-1Rs (Holzer 
1998). Abnormal increase or decrease in NK-1R expression could elevate plasma extravasation, 
immune cells and increased sensitivity of cells to SP released by primary afferent neurons of 
small diameter (Yonehara et al. 1987) providing innervations to the epidermis (Harrison and 
Geppetti 2001).  
Neuromodulator peptide SP, present in C fibers of skin,  play a vital role in tissue repair 
(Delgado et al. 2005). SP modulates epithelial cell migration and restitution in vitro by the 
release of TGF-beta from fibroblasts (Felderbauer et al. 2007) and stimulation of CD29+ stromal 
like cells (Hong et al. 2009). In this way, SP contributes to the protective mechanism of tissue 
repair and maintains a mucosal homeostatis (Felderbauer et al. 2007). It induces cytokine release, 
dilates the blood vessels, increases their permeability and stimulates mast cells to release 
histamine and all these actions are carried by the activation of endothelial cells (Dunnick et al. 
1996). Any dysfunction in the functioning of SP-ergic system may cause delayed wound healing 
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in humans and expression of SP-IR is elevated in wounds and injuries (Onuoha and Alpar 2001; 
Dunnick et al. 1996).  
 
 
Figure 7: Distribution of SP in different systems of body 
Tachykinins are called as brain-gut hormones (Tomita 2009) and SP is found in the gut in 
abundance (Schmidt et al. 2003). They exerts several pathophysiological effects on 
gastrointestinal motor disorders such as diarrhea, gastrointestinal inflammation, visceral 
sensitivity and pain (Holzer 1998), acute intestinal inflammation (Koon et al. 2005), Crohn’s 
disease (CD) (Wang et al. 2006), ulcerative colitis (UC) (Jonsson et al. 2005), acute 
inflammation of colon (Landau et al. 2007), Irritable bowel syndrome (IBS) and inflammatory 
bowel disease (IBD). These disorders are attributed to imbalance of tachykininergic neurons, 
expression, their receptors (Holzer 1998) and neurogenic inflammation by the recruitment of 
immune cells (Sipos et al. 2008). In human histological sections of laryngopharynx and 
gastrointestine of sudden erethistic death and sudden death of heart attach as control, SP-IR was 
found more in the experimental group. Thus alterations in SP expression can serve as a 
diagnostic tool of sudden erethistic death (Sun et al. 2006). 
In the digestive tract (Fig. 7), tachykinins (substance P, neurokinin A) are 
neurotransmitters which regulate motor activity and vascular functions (Holzer 1998). 
Gastrointestinal tract contains intrinsic and extrinsic neurons, both of which have SP-IR 
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innervations (Costa et al. 1986). SP serve as neuroimmunomodulator and controls intestinal 
motility (Lecci et al. 2006), secretion, sensory perception, immune function in intestine (Straub 
et al. 2006), maintains mucosal homeostasis, tissue repair (Felderbauer et al. 2007), mucosal 
permeability (Koon et al. 2008) and has protective role in colitis (Felderbauer et al. 2007). SP is 
involved in secretion of electrolytes and fluid into the lumen of colon by activating cholinergic 
and noncholinergic neurons and by releasing histamine (Kuwahara and Cooke 1990; Lecci et al. 
2006). SP is believed to predominately mediate its effects via NK2 receptors, inducing excitation 
and contraction (Holzer and Maggi 1994), although NK1 may also play a minor role in this 
response (Maggi et al. 1994).  
There are several reports for the involvement of TKs in reproduction (Patak et al. 2000).  
All the TKs and their receptors are found to be expressed  in uterus of superovulated and 
unfertilized mice and may play a role in both male (Clement et al. 2009) and female reproductive 
system (Pintado et al. 2003) (Fig.7). There is a significant up-regulation of NK-1R protein at full 
term fetus and newborn infant with a peak at day 1 and it downregulates at 8th day, which 
indicates that NK-1R may be involved in the mechanisms modulating the processes during 
labour and after birth. SP-IR has an opposite correlation with NK-1R protein expression in 
pregnant and uterus after birth (Schmidt et al. 2003). Another study has different finding and 
suggests that SP expression is elevated at term fetus and soon after birth and has a role in 
cervical ripening and labour mediated by estrogen-ER system, most probably ER-alpha, that is 
systhezised in DRG (Mowa et al. 2003). A role of SP in stress induced abortions, by causing 
neurogenic inflammation, has also been implicated. Under the conditions of stress, SP augments 
the synthesis of decidual Tumor Necrosis Factor (TNF)-alpha, which is a possible trigger of 
miscarriage (Fest et al. 2006; Joachim et al. 2001). 
SP has a role in both normal and pathological hematopoiesis (Nowicki et al. 2007). 
Hematopoietic effects by TKs can be expressed in neural and non-neural tissues. SP is a 
hematopoietic modulator. SP activates bone marrow stromal cells to produce hematopoietic 
cytokines (Adamus 2009). Bone marrow nerve fibers containing SP are a neural SP source while 
stromal SP provides a non-neural source (Rameshwar and Gascon 1997). Hematopoietic effects 
of SP are mediated by NK-1R, bone marrow and growth factors (Rameshwar and Gascon 1995). 
Any imbalance in hematopoietic-neurotransmission immune axis can result in hematological 
malignancies (Adamus 2009). It is also found to be 
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and thrombus formation by mobilizing intracellular calcium and degranulation. Platelets play an 
important role in homeostasis, with inappropriate platelet activation being a major contributor to 
debilitating and often fatal thrombosis by causing myocardial infarction and stroke. SP-IR 
observed in platelets, is secreted during activation and stimulates platelet activation by positive 
feedback mechanism (Jones et al. 2008). SP-mediated platelet aggregation is mediated by NK-
1R (Graham et al. 2004). 
Metabolism of skeletal system is controlled by the nervous system. About 10 
neurotransmitters have been identified in bone and SP is one of them (Liu et al. 2007). 
Tachykinin peptide SP and its receptor NK-1R has been found in bone cells (Goto et al. 2007) 
where they are known to stimulate the process of repair, formation and resorption of bone (Li et 
al. 2010) mediated by NK-1Rs at late stage bone formation (Goto et al. 2007). SP receptors are 
localized in osteoclasts (Liu et al. 2007). SP is also involved in nociceptive responses in bone 
e.g. pain produced by cervical facet joint distractions (Lee and Winkelstein 2009) and 
osteoporosis (OP) (Liu et al. 2008).  
2.4 Trigeminal System 
Trigeminal system is highly established and well  studied  system in mammals and birds 
(Davies 1988).  SP-IR has been observed in trigeminal (Lee et al. 1985) and dorsal root ganglia 
(DRG) (Gibbins et al. 1987). Main feature of this system is the presence of two distinct groups of 
primary afferent neurons: Trigeminal Ganglion (TG) and Mesencephalic Trigeminal nucleus 
(MTN). Cell bodies of these primary afferent neurons are present in TG (Lazarov 2000) and few 
lie in MTN. MTN is involved mainly in proprioception (mainly orofacial musculature) (Nagy et 
al. 1986). TG dorsomedial part is involved in nociception, thermoreception and proprioception 
while TG ventrolateral part is involved in mechanoreception (Lazarov 2002). Signals from the 
trigeminal system are transmitted by second order neurons in brainstem to different regions of 
CNS pain centers (Eftekhari et al. 2010). The central processes of the TG terminate on several 
groups of second order neurons, whose impulse are conveyed to the somatosensory cortex via 
thalamus (Pfaller and Arvidsson 1988) (Fig. 8). 
2.4.1 Trigeminal Ganglion 
Trigeminal ganglion (TG) is accumulation of pseudounipolar neurons (Krastev 2008) and 
consists of neurons and their fibers. TG is the center of interest for studying the expression of SP 
due to the activation of the trigeminal nerve system found in this study in the brainstem of 
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perinatal death victims as compared to the normal ones. TG is a cranial analog of DRG in PNS 
(Lazarov 2002). Activation of TG nerves play a central role in most forms of orofacial pain 
(Takemura et al. 2006). A variety of transmitters and their receptors have been described in 
different subsets of TG neurons (Lazarov 2002). TG neurons supply innervations mostly to the 
mechanoreceptors, receptors for thermoregulation and pain regulation in face, oral and nasal 
cavity (Dubner 1978; Davies 1988). Glial cells also known as satellile cells (Pannese 1981) 
completely enclose the neuronal somata of TG neurons and thus they have no synaptic contacts 
(Lieberman 1976). 
 
 
Figure 8: Processing of nociceptive stimulus within brain 
Based on their appearance, ganglion cells are classified as follows: large light (A) and 
small dark (B) cells (Gaik and Farbman 1973). Thick myelinated fibers originate from large light 
A cells and thin myelinated and unmyelinated C fibers derive from small dark B cells (Scharf 
and Rowe 1958). Two primary afferent neurons subpopulations are noticed in TG: Small and 
medium sized neurons with small somata, including a number of Glutamate (Glu), Substance P 
(SP), Somatostatin (SOM), Neurokinin A (NKA), CGRP, Cholesystokinin (CCK), Vasoactive 
intestinal peptide (VIP) and Galanin-IR and larger sized neurons that are relatively less and 
includes neuropeptide Y (NPY) and Peptide 19 (PEP 19)-IR trigeminal neurons. The majority of 
large ganglion cells are surrounded by SP, CGRP, SOM, CCK, VIP, NOS and SER-IR 
periosmotic networks (Lazarov 2002). Presence of SP in small diameter primary afferent fibers 
and in nociceptive centers of brain gives us an idea of its nociceptive role (Hunt and Rossi 1985; 
Levine et al. 1993).   
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2.4.1.1 Trigeminal Nerve 
Trigeminal ganglion provides somatosensory innervations of face and oral cavity through 
trigeminal nerve. Trigeminal nerve is 5th and the largest of cranial nerves and its name is derived 
from the fact that it has 3 major branches each providing inervation to distinct regions of head, 
face and oral cavity  (Voogd and Glickstein 1998). V1 and V2 are purely sensory while V3 (Fig. 
9) has both sensory and motor functions. V1 innervates forehead, upper eyelid, cornea, 
conjunctiva, mucosa of frontal ethmoid and sphenoid sinuses and dorsum of nose (Fig. 9). V2 
innervates upper lip, lateral portions of nose, parts of oral cavity, mucosa of nasal cavity, 
maxillary sinus, upper jaw and roof of mouth and upper dental arch while V3 innervates lower 
lip, chin, cheek, lower teeth, gingival, mucosa of lower jaw, floor of mouth and anterior two 
thirds of tongue (Usunoff et al. 1997; Takemura et al. 2006) (Fig. 9).    
 
                           A                                                                     B                                                    C 
Figure 9: Trigeminal nerve and its branches; A: Brainstem exhibiting 12 cranial nerves, 
trigeminal nerve is 5th, B,C: Trigeminal nerve providing innervations to forehead, eyes (V1); to 
upper lip, oral cavity, upper jaw (V2) and to lower jaw, chin, lower lip and tongue (V3) 
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2.4.1.2 Structural Organization of Trigeminal Nerve Nucleus 
Trigeminal nerve nucleus is composed of three nuclei, mesencephalic, chief sensory and 
spinal trigeminal nucleus (Fig. 10) and two types of glial cells; satellite glial cells and schwann 
cells (Hanani 2005; Hanani 2010). Spinal trigeminal nucleus is located caudally and nociceptive 
sensory information from orofacial region is first processed here.  This nucleus is further divided 
rostro-caudally into subnuclei oralis, interpolaris and caudalis (Vc) (Olszewski 1950) (Fig. 10). 
Nociceptive information from face and oral cavity is first processed in Vc (Sessle 2000) through 
the release of SP (Aita et al. 2005). Trigeminal primary afferent neurons conduct 
neurotransmission by peptide transmitters, calcium binding proteins and other neuroactive 
molecules (Lazarov 2000). Environmental factors and stressors alters the neuronal content of 
these transmitters (Copray et al. 1990). Among all the TKs, SP undoubtedly acts as a transmitter 
substance in primary sensory neurons (Konishi and Otsuka 1985). 10-20% of TG cells show 
strong IR to both SP and NKA (Tornwall et al. 1994). Earlier IHC studies indicate that SP is 
present in primary sensory neurons of TG in almost all mammals (Hokfelt et al. 1976), e.g. 
guinea pigs, rats, monkeys (Terenghi et al. 1985), rabbits (Tervo 1981), cats (Lazarov and 
Chouchkov 1996) and humans. Furthermore, in human TG, the percentage of SP containing cells 
varies with age, declining from about 24% in newborns to about 17% in adults (Del Fiacco et al. 
1990). Neuropeptides in the trigeminal sensory neurons have significant functions in disease 
mechanisms associated with head pain in humans (Goadsby et al. 1988; Otsuka and Yanagisawa 
1990).  
The trigeminal subnucleus caudalis (Vc) is critical site for the processing of pain stimulus 
from orofacial region (Aita et al. 2005). Trigeminal pain processing has been extensively studied 
in trigeminal subnucleus caudalis (Vc) (Fig. 10) and now studies are focusing on other aspects of 
trigeminovascular system beyond Vc or MDH (Bereiter et al. 2000),(Dubner and Ren 
2004),(Ren and Dubner 1999). Activation of neurons in ventral portion of Vi/Vc transition zone 
along with caudal part of Vc has been observed after orofacial injury (Strassman and Vos 
1993),(Hathaway et al. 1995). Various studies suggest that glia and inflammatory cytokines are 
involved in the development of constant nociception (Ren and Dubner 2008; McMahon et al. 
2005). Transition zone of Vi/Vc contributes to the deep orofacial pain processing (Chattipakorn, 
et al. 2002). 
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Figure 10: Graphical representation of Trigeminal nerve nucleus (TrN) 
2.4.2 Mesencephalic Trigeminal Nucleus 
Subpopulation of large sized neurons in Mesencephalic Trigeminal Nucleus (MTN) exhibit 
Glutamate immunoreactivity. Most of the interneurons in MTN are  GABAergic and other 
neurotransmitters are not found here (Lazarov 2002). A single identified nucleus in CNS that has 
cell bodies of primary afferent neurons is MTN (Johnston 1909; Freeman 1925). Another 
peculiarity of MTN is that they are “ proprioceptive neurons” of the trigeminal system (Dubner 
1978; Davies 1988). MTN neurons mostly innervate muscle spindles in the masticatory (Capra et 
al. 1985; Alvarado-Mallart et al. 1975) and extraocular muscles (Alvarado-Mallart et al. 1975) 
and other types of receptors in the periodontal ligaments (Byers and Dong 1989; Linden et al. 
1994) and dental pulp (Yoshino et al. 1989). MTN neurons are functionally homogeneous 
(Linden 1978) and without exception are involved in sensory aspects of orofacial proprioceptive 
information processing while trigeminal Primary afferent neurons are chemically heterogeneous 
(Lazarov 2000).       
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Figure 11: Brainstem showing trigeminal nucleus and also show the level of sampling A) 
Ventral view B) Side view: showing trigeminal nerve, mesencephalic, chief sensory and spinal 
trigeminal nucleus (Kahle and Frotscher 2005). 
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CHAPTER III 
AIM OF STUDY 
The goals of this study were:   
1) to obtain basic information about the expression of the SP during the first phases of  
human nervous system development; 
 2) to evaluate whether there are altered manifestations of this neuromodulator in victims 
of sudden death; 
 3) to verify the correlation with maternal cigarette smoking. 
4) to understand the network properties, evolution and duplicability of the gene encoding 
substance P (Tachykinin 1) by computational analysis. 
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3 Material and Methods 
A total of 56 brains were collected from 24 fresh human fetuses (17-40 gestational 
weeks) and 32 infants aged 1-10 months. In 36 cases, after the in-depth anatomo-pathological 
examination the death remained totally unexplained. A diagnosis of SIUD (sudden intrauterine 
unexplained death) was established for 16 fetuses, who died suddenly before complete expulsion 
or retraction from the mother, and of SIDS (sudden infant death syndrome) for 20 infants who 
died within the first year of life. In the remaining 20 cases, 9 stillbirths, and 11 infant deaths, a 
precise cause of death was formulated at autopsy.  These cases were used as controls. The related 
infant death diagnoses in this group were: congenital heart disease (n=5), severe 
bronchopneumonia (n=2), myocarditis (n=1), pulmonary dysplasia (n=2), and 
mucopolysaccharidosis type I (n=1). Specific diagnoses among the fetal deaths included: 
chorioamnionitis (n=6) and congenital heart disease (n=3).  
This was a selected set of cases, all sent to “L.Rossi” Research Center in application of 
the 2006 guidelines stipulated by Italian law n.31 “Regulations for Diagnostic Post Mortem 
Investigation in Victims of SIDS and Unexpected Fetal Death”. This law decrees that all 
infants with suspected SIDS who died suddenly in Italian regions within the first year of age, as 
well as all fetuses who died without any apparent cause, must undergo, after parental consent, an 
in-depth anatomo-pathological examination, particularly of the autonomic nervous system 
(Matturri et al. 2005; Matturri  et al. 2008).  Permission from ethic committee was not required 
for this study as our Research Center is the referral national center for the sudden unexplained 
fetal and infant death, according to above-mentioned Italian Law n. 31. 
For every case, a complete clinical history was collected.  Additionally, mothers were 
asked to complete a questionnaire on their smoking habit, detailing the number of cigarettes 
smoked before, during and after pregnancy. Fifteen of the 36 SIDS/SIUD mothers (42%) were 
active smokers before and during the pregnancy, smoking more than 3 cigarettes/ day. The 
remaining 21 mothers (58%) admitted no history of cigarette smoking.  Four of the 20 mothers in 
the control group (20%) reported a smoking habit, while the remaining 16 mothers (80%) were 
non smokers.  
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3.1 Protocol for the examination of Brainstem 
Anatomo-pathologic study of the brainstem (medulla oblongata, pons and midbrain) 
includes sampling of three specimens (Fig. 12), after fixation for 3-4 days in 10% buffered 
formalin. Structures participating in control of the vital functions are located (cardiorespiratory, 
arousal, upper digestive tract, etc) here. The first specimen, ponto-mesencephalic, includes the 
upper third of the pons and the adjacent portion of mesencephalon.  The second extends from the 
upper third of the medulla oblongata to the portion adjacent to the pons.  The third specimen 
takes as reference point the obex and extends 2-3 mm above it and below it (Fig. 12 and 13).   In 
all cases, it is important to avoid pulling of leptomeninges, as it will cause damage to the ventral 
surface of medulla oblongata. This simple procedure of brainstem examination in both fetus and 
infant, provides a significant reduction of sections to just 3 samples of medulla oblongata and 
allow to examine the various nuclei in cranial, middle and caudal part of pontine-mesencephalic 
sample. 
 
 
Figure 12: Sampling of the brainstem from brain ventral (left) and dorsal (right) surface.  
Structure of brainstem [Modified from L. Testut, “Anatomia Umana”, Unione Tipografico-
Editrice Torinese, Torino, 1923] 
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3.2 Preparation of solutions 
Solutions were prepared with distilated water. Citrate buffer, Phophate buffered saline 
(PBS), Xylene, Acetone, Alcohol, Hydrogen peroxide were used in this study. All solutions used 
are named in the text. 
3.2.1 Preparation of Phosphate buffered saline (PBS) 
Dissolved one tablet of PBS (Sigma, Batch no. 124K8202) in 200 ml of distilled water 
and stored it at 5ᵒC 
3.2.2 Preparation of Citrate buffer 
Dissolved one tablet (Sigma, Lot no. 123K8209) in 100ml of deionized water to obtain 
0.05 M phosphate citrate buffer (PH 5.0). 
3.2.3 3% Hydrogen peroxide solution 
For preparing 3% Hydrogen peroxide solution, I used 6ml of 30% Hydrogen peroxide 
(PROLABO) in 200ml of PBS. 
3.2.4 Blocking Serum (Normal Serum) 
Added three (3) drops (150 µl) of stock (yellow label from ABC kit) to 10 ml of buffer 
(PBS) in mixing bottle (yellow label). The preferred serum for blocking is prepared from the 
same species in which the biotinylated secondary antibody is made. Apart from blocking serum, 
ABC kit also has biotinylated secondary antibody and ABC reagent. 
3.3 Primary Antibody 
Rabbit Polyclonal Anti-Substance P 4-11, conjugated to thyroglobulin, ARP (American 
Resarch Products), Inc., 1:80  
3.4 Secondary Antibody 
Biotinylated secondary antibody from Avidin Biotin Complex kit (ABC kit Vectastain, 
Vector laboratories Inc. Burlin game, CA, USA). Added three (3) drops (150 µl) of normal 
blocking serum stock from ABC kit (yellow label) to 10 ml buffer (PBS) in mixing bottle and 
then added one (1) drop (50 µl) of biotinylated antibody stock (blue label from ABC kit). 
3.5 Dyes, Substrates, Pretreatment, Embedding Media, Counterstains and Mountant  
3.5.1 Embedding Media  
BioPlast Paraffin wax was used for embedding (Bio-Optica) having a melting point of 
57-58ᵒC. 
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3.5.2 STA-ON 
Tissue section adhesive was put in hot water bath while shifting the sections from water 
bath to slides. 
3.5.3 ABC Reagent  
Added exactly two drops of REAGENT A (gray label from ABC Vectastain kit) to 5 ml 
of buffer (PBS) in the ABC Reagent large mixing bottle. Then added exactly two drops of 
REAGENT B (gray label) to the same mixing bottle, mix immediately, and allowed to stand the 
reagent for 30 minutes before use. 
3.5.4 Horseradish Peroxidase Substrates  
Diaminobenzidine (DAB) (Vector laboratories) substrate kit was used which yields a 
brown chromogenic precipitate. This solution is made immediately before use. To prepare the 
substrate solution, I took 5 ml of distilled water, added two drops of buffer stock solution and 
mixed it well. Then added 4 drops of DAB stock solution and mix it well again. Added 2 drops 
of hydrogen peroxidase solution in this solution and mixed it thoroughly. 
3.5.5 Dyes and Counterstains 
 Methyl green was used for counterstaining of nuclei. It was prepared by dissolving 1g of 
methyl green powder in 1ml of glacial acetic acid and then it was mixed in 99ml of distilled 
water to make the volume 100ml. Solution was then mixed on stirrer without heating. Solution 
was filtered through a 0.45 or 0.2 micron filter prior to use. 
3.5.6 Mountant 
 DPX mountant (BDH chemicals Ltd. Poole England). 
3.6 Equipment  
Unless stated otherwise, general lab equipment was used for the immunohistochemical 
techniques, including–stop watch, microscope, balances, heating and stirring hot plate, 
incubation ovens, fridge and refrigerators, micropipettes, pH meter, whatman filter paper, 
chemical hood, vortex mixer and waterbaths. Glassware included graduated cylinder, flask for 
filteration, volumetric bottles for solutions, slides, coverslips, coplin jars and beakers of different 
sizes. Plastic ware includes Wet chambers, slide racks with removeable handles, test tube racks, 
pipette stands, heat and chemical resistant coplin jars. Sections were obtained using the 
microtome LEITZ model 1400. A NIKON EClLIPSE E800M was used to document whole 
mount images. 
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3.7 Processing of Brainstem Manually 
After fixation in 10% phosphate-buffered formalin, the processing of the brain stem and 
spinal cord was done manually, using different grades of alcohol for dehydration and xylene 
located under the hood and then samples were embedded in paraffin. This grading scale of 
alcohol was used for brainstem and many cases can be processed at the same time because the 
samples are in small plastic cages (megacassettes) or small bags and appropriately marked by the 
case number, and the sample inside. When samples are more, they should be put in larger 
containers and processed always under hood. Reagents were changed or atleast filled after each 
processing, when reagents level was decreased.  
3.8 Embedding of Brainstem Tissue Sample 
The brainstem and cerebellum, the main structures analyzed in our studies, were 
processed and embedded in paraffin. After embedding, it was allowed to cool down in fridge for 
overnight.  
3.9 Protocol for Histology of Brainstem 
 Transverse serial sections of the midbrain, pons, medulla oblongata, and cerebellum 
samples were made at intervals of 20-30 µm. For each block, 15 levels were cut and 12 serial 
sections (1 HE+3 normal blank+8 treated with silane) of 5 µm each were obtained from each 
level by using STA-ON (in water bath). Slides were placed in oven at 37ºC overnight. In the next 
morning, took one slide for histological examination using hematoxylin-eosin, one was 
submitted to immunohistochemical study of SP and the remaining sections were saved and 
stained as deemed necessary for further investigations. Klüver-Barrera is done if required.  
The routine histological evaluation of the brainstem was focused on the locus coeruleus 
and the parabrachial/Kölliker-Fuse complex in the rostral pons/caudal mesencephalon, on the 
retrotrapezoid nucleus, the superior olivary complex and the facial/parafacial complex in the 
caudal pons; on the hypoglossal, the dorsal motor vagal, the tractus solitarius, the ambiguus, the 
pre-Bötzinger, the inferior olivary, the raphe and the arcuate nuclei in the medulla oblongata. In 
the cerebellum, the cortex layers (external granular layer, molecular layer, Purkinje cell layer and 
internal granular layer) and the medullary deep nuclei (the dentate nucleus, the fastigial nucleus, 
the globose nucleus and the emboliform nucleus) were examined.  
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3.10 Hematoxylin-Eosin Staining 
For HE staining, slides were placed in xylene I and II for 10 minutes each and then in 
different grades of alcohol in decreasing manner from absolute to 60% (100%,95%,80% and 
60%) to hydrate them. Washed the slides with tap water for 5 minutes and then stained them with 
Mayer hematoxylin for 15 minutes. Slides were put under running water for 10 minutes. Colour 
of hematoxylin changed from violet to blue. Placed the slides in 0.5% Eosin for 13 seconds and 
dipped in water once. Dehydrated the slides by giving one dip in grades of alcohol in increasing 
manner (60%,80%,95% and 100%). Slided were put in xylene III and then xylene IV for 5 
minutes each and then mounted. 
 
Figure 13: Diagram of the histological sections corresponding to the three fragments obtained 
from the sampling procedures of brainstem for the anatomo-pathologic examination, indicating 
the main nuclei and structures to be examined.   
3.11 Preparation of Slides for immunohistochemistry 
To inhibit binding of antibodies to slides and to help in adhesion of sections to slides 
stongly (during immunohistochemical reactions and heating in oven), slides were pre-treated 
with 3-Aminopropyl triethoxy silane (Sigma, Code No. 3648). Slides were put 3 times in 70% 
alcohol with HCl 1% for 10 minutes and then a solution of acetone I and chloroform (1:1) was 
used to wash slides for 10 seconds. Slides were then placed in a solution of 3-Aminopropyl 
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triethoxy silane and acetone (1:25). Slides were given another wash in solution of acetone + 
chloroform (1:1) for 30 seconds and in ditilated water for 15 seconds. Then slides were placed in 
oven at 37ᵒC overnight. 
3.12 Substance P Immunohistochemistry (IHC) 
 Sections were deparrafinized with xylene 1, xylene II and different grades of alchohol 
(100%, 90%, 70%), washed in distilled water and then phosphate buffered saline (PBS). The 
slides were pretreated in a microwave oven using citrate buffer (PH=6) (3X for 1 minute at 
440W, 4 minute at 250W). Slides were then allowed to cool for 20 minutes. Blocking of 
endogenous peroxidase was done by using 3% H2O2 for 30 minutes after washing with distilled 
water and phosphate buffered saline.  Sections were incubated overnight with primary rabbit 
polyclonal anti-substance P (4-11) antibody at a dilution of 1:80 after washing with phophate 
buffered saline. Immunohistochemical staining was performed by using peroxidase-
antiperoxidase method and the avidin biotin complex technique (ABC kit Vectastain, Vector 
laboratories Inc. Burlin game, CA, USA) for 30 minutes. Diaminobenzidine (DAB, Vector 
Laboratories Inc.) was used as chromogen substrate and sections were incubated in DAB for 15 
minutes and counterstained with methyl green for 15 minutes at 60ºC. Sections were given quick 
wash in acetone I and then again in acetone II for 10 minutes. Negative controls of the same 
tissue were done using phosphate-buffered saline instead of primary antibody. Sections were 
washed in xylene I and II for 5 minutes each and mounted. 
The examination of slides was performed in blinded fashion, without initial knowledge of 
the cause of death, age or other clinicopathologic information. Only after the histologic and 
immunohistochemical assessment of the brainstem and cerebellum had been completed, the 
findings were matched with the corresponding records. 
3.13 Statistical analysis 
The association between immunohistochemical data, the main target of this study, and 
victim groups was evaluated by Cox regression analysis. The statistical value of the correlation 
was established at the p<0.05 level using one way analysis of variance followed by t-test or 
Student’s t-test. 
3.14 Data mining for TAC1  
I have also looked at the system level properties such as genomic duplication, network 
properties and evolution of TAC1 gene. Firstly, I searched orthologs of TAC1 by using eggNOG 
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Version 2.0 (http://eggnog.embl.de). I found TAC1 gene in 26 species of vertebrates and then 
multiple sequence alignment was performed for the subsequent computational analysis.  
3.14.1 Genomic duplicability of TAC1 gene 
To find duplicates or paralogs of TAC1 in human genome, I have used UCSC (University 
of California Santa Cruz) genome browser (www.genome.ucsc.edu). It uses BLAT (BLAST like 
Alignment tool) for the sequence alignment of proteins and DNA. I considered a gene as 
duplicate if it has additional hit on the genome and as singletion if it has only one hit on the 
genome. 
3.14.2 Phylogenetic analysis.of TAC1 gene 
MAFFT, online version 6.0 (http://align.bmr.kyushu-u.ac.jp/mafft/online/server/), was 
employed for multiple protein alignments using the E-INS-i strategy with the default parameters. 
To estimate the phylogenetic relationships of the sequences I performed distance-based analyses 
using the Neighbor Joining (NJ) (a bottom up clustering method used for the construction of 
phylogenetic trees) programs.            
3.14.3 Network properties of TAC1 gene 
Predictions for TAC1 interactors were performed using STRING 8.3 database (string-
db.org). It is a database of known and predicted protein-protein interactions. The interactions 
include direct (physical) and indirect (functional) associations. They are derived from the sources 
of gemomic context, high throughput experiments, conserved coexpression and PUBMED. 
3.14.4 Generation of Amino acid Sequence Logos 
Sequence logos were generated using a web-based program, Weblogo, version 3.0 
(http://weblogo.threeplusone.com/) developed by Crooks (Crooks  et al. 2004) and Schneider and 
Stevens (Schneider and Stephens 1990). A logo was generated with amino acid sequences from 
preprotachykinin 1 gene of 26 vertebrate species (Fig. 23) including homosapiens. It is a web 
based application designed to generate sequence logos. Sequecne logos are a graphical 
representation of an amino acid or nucleic acid multiple sequence alignment. Each logo consists 
of stacks of symbols, one stack for each position in the sequence. The overall height of the stack 
indicates the sequence conservation at that position while the height of the symbols within the 
stack indicates the relative frequency of each amino or nucleic acid at that position. 
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CHAPTER IV 
4 RESULTS 
Firstly, we proceeded to define the localization of the SP-IR (Substance P 
immunoreactivity), the target of this study, in the brainstem of fetal and infant control cases. SP-
positivity appeared mainly in fiber-structures, mostly comprised of dot-like varicosities and with 
densities varying from low to very high. These SP-IR fibers, generally surround non-IR neurons. 
Only a low number of SP-immunoreactive perikarya was sometimes found. Strong 
immunopositivity was constantly observable, in the area of the trigeminal nucleus (TrN) in the 
dorsolateral part of the medulla and in rostral spinal cord both before and after birth.  
 
Figure 14: Photomicrograph of a transverse histological hemisection of medulla oblongata 
(dorsolateral portion) of a fetus of control group (died at 18th gestational weeks), showing in the 
boxed area (magnified in B) the trigeminal nucleus with poor number of positive fibres of the 
tract. Substance P immunostain. Magnification: A) 10x; B) 20x 
Given the constant presence of SP-immunostaining in the TrN (Trigeminal nucleus), we 
tried, with the help of the immunohistochemistry and following the indications exclusively 
provided by experimental studies in this field (Luccarini et al. 1998; Phelan and Falls 1989; 
Athanassiadis et al. 2005), to elicit basic data on the morphological and functional 
developmental steps of this nucleus, so difficult to identify in histological sections of human 
brainstem, due to its indefinite boundaries.  Classical studies in rodents consider this nucleus as a 
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neuronal complex including, throughout its extension, the “principal sensory nucleus” in the 
pons and the “spinal trigeminal nucleus” located in the medulla and rostral segments of the 
spinal cord. The spinal TrN is divided into three subnuclei, the oral, the interpolar and the caudal 
(Fig. 10), adjacent to the spinal trigeminal tract that appears to be layered on transversal sections. 
The spinal caudal subnucleus, in turn, includes a magnocellular core, composed of medium-large 
sized cells with abundant Nissl substance. 
                       
Figure 15: SP-IR of fibers in trigeminal nucleus, with interstitial island of immunonegative 
neurons, in an infant died at 4 months of life of bronchopneumonia. Substance P immunostain. 
Magnification: 40x 
4.1 Developmental cytoarchitecture of the human spinal TrN in control fetal and infant 
deaths 
At the earliest observation (17th-18th gestational week) the TrN in the coronal sections of 
medulla oblongata and rostral spinal cord (corresponding to the “spinal TrN” in rodents) shows 
low number of positive fibres in correspondence of the tract, surrounding undifferrentiated small 
rounded neurons, without defined outlines (Figure 14 A and B). This cytoarchitectonic feature 
persists in the following gestational weeks, with the only difference that the tract is increasingly 
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thickened and stratified. The marginal immune-negative cells frequently appear medium-sized 
and pear-shaped or polygonal with sketchy axons and dendrites.   
The most conspicuous positive SP-fibre plexus of the spinal TrN is found at birth and in 
the first months of life, with interstitial island of immunonegative neurons embedded in bundles 
of the tract (Figure 15). Precisely, SP-immunoreactive fibres, that appear to be layered in 
transversal sections, form distinct pericellular arrays around the somata and dendrites of neurons. 
These interstitial cells show various edges: triangular, rounded, polygonal or star-shaped. They 
send thin dendrites interconnecting the cells and achieving the plexus.  
 
Figure 16: Magnocellular core (see arrow) of spinal trigeminal nucleus in infant of contol group 
aged 2 months at A: lower (20X) and B: higher (40X) magnification of large neurons. Substance 
P immunostain.  
A magnocellular group consisting of large lightly stained neurons with peripheral Nissl 
substance, either grouped or disseminated, are also found at these levels, corresponding to the 
magnocellular core of the caudal subnucleus in rodents (Figure 16 A and B). We can identify the 
oral limit of the human spinal caudal subnucleus and the shift to the interpolar TrN in 
correspondence of the disappearance of these neurons. Overall, we observed during development 
a slight, progressive increase of the spinal TrN outlines, and in particular of the tract and 
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neuronal cell body areas, whereas the neuronal density remained steady. In infant deaths, in 
addition to the TrN, the raphé complex and the reticular formation displayed a variable density of 
SP-immunoreactivity (Figure 17). 
4.2 Neuropathology of the spinal TrN in unexplained perinatal death and SIDS 
We observed different distribution of SP-binding sites limited to the spinal TrN in 21 
victims of unexplained death (33%) compared with the age-matched controls. Precisely, dense 
plexus of SP immunoreactive fibres in the TrN area were found in 10 SIUD victims (Figure 18) 
and, conversely, depletion or fewer reactive fibres in 11 SIDS subjects (Figure 19).   In addition, 
in 5 of these 11 cases we diagnosed hypoplasia of the TrN, given the presence of rare interstitial 
neurons and total absence of large cells in the magnocellular area of the caudal trigeminal 
subnucleus (Figure 20).  
 
Figure 17: SP-immunopositivity of the raphe obscurus nucleus and of the reticular formation in 
control infant aged 3 months. Substance P immunostain. Magnification: 10x 
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4.3 Relation with smoking exposure 
A significant correlation was observed between altered expression of SP in TrN and the 
mother’s smoking habit. In fact, 17 of the 21 victims of sudden death with TrN neuropathology 
had a smoker mother (p <0.05).  
 
Figure 18: Dense plexus of SP-IR fibers in the trigeminal nucleus area in a SIUD victim aged 32 
gestational weeks.Substance P immunostain. Magnification: 20x 
4.4 Brainstem pathological results overall 
Table 4 summarizes all the neuropathological findings in the brainstem. Besides to 
alterations of the spinal TrN, a subset of SIDS cases had hypoplasia of the medullary arcuate 
nucleus or of the pre-Botzinger complex, or different raphe nuclei. A subset of SIUD cases had 
hypoplasia of the pre-Botzinger complex or the parafacial nucleus or different raphe nuclei. A 
small subset of controls, both fetal and infant deaths, had hypoplasia of the arcuate nucleus 
and/or the raphé obscurus nucleus.  In all, a significantly greater proportion of neurological 
alterations were observed in SIDS-SIUD cases compared with controls (p<0.01). The more 
frequent association was between alterations of SP signalling in TrN and pre-Bötzinger complex 
hypoplasia. In fact, 17 of the 21 victims of sudden death with alterations of TrN SP-IR (including 
the 5 cases with TrN hypoplasia) showed hypoplasia/agenesis of the pre-Bötzinger complex 
(p<0.01). 
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Figure 19: Poor immunopositivity of fibers in the trigeminal nucleus area in SIDS victim 3 
months old. Substance  P immunostain: Magnification 20X 
 
Figure 20: Hypoplasia of the trigeminal nucleus with depletion of immunopositive fibers and 
rare interstitial neurons. Substance P immunostain: Magnification 20X
63 
 
 
Study group Arcuate 
nucleus 
hypoplasia 
 
number of 
cases (%) 
Pre-Bötzinger 
complex 
hypoplasia 
 
number of 
cases 
(%) 
Parafacial 
nucleus 
hypoplasia 
 
number of 
cases 
(%) 
Raphé nuclei 
hypoplasia 
 
number of 
cases 
(%) 
SP alterations 
in trigeminal 
nucleus 
number of 
cases 
(%) 
SIDS 
n=20 
9  
(45%) 
 
9  
(45%) 
- 7  
(35%) 
11b 
(55%) 
Infant 
Controls 
n=11 
2 
(18%) 
- - 3 
(%) 
- 
SIUD  
n=16 
7  
(44%) 
8 
(50%) 
6  
(37%) 
 
4  
(25%) 
10a 
(65%) 
Fetal 
Controls 
n=9 
2 
(22%) 
- - 1 
(11%) 
- 
 
a  : increased SP-expression                   b : decreased expression 
Table 4: Overall neuropathological brainstem findings in 20 SIDS, 16 SIUD and 20 controls 
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4.5 COMPUTATIONAL ANALYSIS 
I have also studied the system level properties, such as gene duplicability, gene appearance in 
evolution, protein-protein interaction network and amino acid sequence conservation in prepro-
tachykinin 1 precursor gene (TAC1) from 26 vertebrate species and structure of its receptor NK-
1R (Fig. 4). I found by using BLAT (Fig. 21) that TAC1 has no additional hit on human genome, 
suggesting that it is a singleton gene and a single copy in the genome makes it functionally 
essential (Fig. 21). A small perturbation to this gene could lead to fatal outcome. By looking at 
the evolutionary tree (Fig. 23) of TAC1 suggests that it has appeared at the level of vertebrates 
and is a new gene. It also suggests that it has a role specific to the organisms with advanced 
nervous systems and it is brain specific, required for the sophisticated functions. We already 
know that TKs are present in both lower and higher vertebrates but they are much more 
advanced and authentic in mammals. They are highly diversified and established in mammals. In 
mammals they are involved in regulation of several important functions such as developmental 
processes, differentiation of cell, brain development, axon guidance, neurotransmission, immune 
modulation, mood control, behavioural responses, gastrointestinal contractions, lung and airway 
functions, response to environmental stress, learning and memory. 
 
 
Figure 21: BLAT results of human TAC1 gene 
TAC1 protein-protein interaction network (Fig. 22) shows that it interacts with 10 proteins, 
that includes TACR1, TACR2, TACR3, TAC3, TAC4, CALCB (calcitonin gene related peptide 
precursor 2), CALCA (calcitonin gene related peptide precursor 1), NGFB (Beta nerve growth 
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factor precusor), VIP (Vasoactive intestinal protein) and NR3C1(glucocorticoid receptor).  
Among 10 protein interactors 5 belongs to TK family and other interactors such as CGRP 
(CALCA and CALCB), NFGB, NR3C1 and VIP also have similar roles such as TAC1 encoded 
product SP like vasodilation, inflammation, muscle contractility. CGRP and NGFB are abundant 
in CNS and have important roles in development of CNS and PNS like SP. WebLogo diagram of 
TAC1 gene (Fig. 24) depicts the conserved amino acid sequence F-X-GLM, particular of 
tachykinin family in these 26 vertebrate species. 
 
                     
Figure 22: Protein-protein interaction of TAC1 gene by using STRING 8.3 
66 
 
.  
 
 
Figure 23: Phylogenetic tree of TAC1 gene by using MAFFT online version 6.0 
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Figure 24: Amino acid sequence conservation in the vertebrate prepro- TAC1 gene from 26 species. 
Conservation is displayed as a sequence logo. Sequence logos were generated as described (Kraemer et 
al. 2008) by using WebLogo version 3.0 (http://weblogo.threeplusone.com). In this representation, the 
relative frequency with which an amino acid appears at a given position is reflected by the height of its 
one letter amino acid code in the logo, with a total height at a given position proportional to the level of 
sequence conservation (see material and method). Tachykinin 1 (TAC1) encodes for SP, NP gamma, 
NPK, NKA and this preprotachykinin 1 sequence also shows signal peptide, C terminal flanking sequence 
and propeptide. Preprotachykinin is cleaved into mature peptides after differential splicing. Sequence in 
purple box shows highly conserved signature motif of tachykinin family. 
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5 DISCUSSION 
The respiratory control system is influenced by classical neurotransmitters and by 
neuromodulators. The neuromodulators are neuroactive substances that can be secreted at a 
distance from their receptors and can have a non-synaptic transmission via the intercellular 
spaces. Neuromodulators that are considered seriously as natural participants in central 
respiratory control include dopamine, adenosine, endorphins, serotonin, and substance P (SP) 
(Moss and Inman 1989; Moss et al. 1986; Hilaire and Duron 1999; Bonham 1995). SP in 
particular is a member of the tackykinin family of neuropeptides that, besides to play a role in the 
modulation of hemodynamic function and neuronal pathways related to pain sensation (Nicoll et 
al. 1980), is involved in the breathing acceleration under conditions of hypoxemia (Lagercrantz 
et al. 1991; Hedner et al. 1981). It can be highlighted, such as many neurotransmitters, by a 
specific immunohistochemical method.   
Abnormal distribution of different neurotransmitters involved in breathing control 
(namely somatostatin, serotonin, catecholamines) (Lavezzi et al. 2004, 2005, 2009) has been 
observed, by our lab previously, by immunohistochemistry in the brainstem of sudden perinatal 
death and SIDS victims. These alterations were thought to cause drawback of vital functions 
and/or induction of fatal breathing in prenatal life and worsening of ventilatory control in 
newborns, easily leading to irreversible apnea.  
In the present study we aimed to enlarge our knowledge by evaluating the expression of 
SP in these pathologies. Therefore we investigated the SP-immunoreactivity (SP-IR) in subjects 
aged from 17 gestational weeks to 10 postnatal months, who had died of both known and 
unknown causes. Our aim was, besides to obtain basic information about the distribution of SP 
binding sites in the first phases of the human nervous system development, to evaluate the 
possible presence of SP alterations in cases of sudden perinatal and infant death, in addition to 
the morpho-functional troubles of the autonomic nervous system already reported (Lavezzi et al. 
2004; 2005; 2006; 2007; 2009; Matturri et al. 2002; Lavezzi and Matturri 2008). 
A topographical mapping of SP immunoreactive structures in the human brain have been 
reported in the past by several authors but with many disagreements in the demonstration of the 
SP-binding sites (Chigr et al. 1991; Jordan et al. 1995; Del Fiacco et al. 1984). This study 
provides a detailed report of the distribution of SP-immunoreactivity (SP-IR) within the human 
fetal and infant brainstem. We detected SP positivity from early stages of ontogenesis mainly in 
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the dorsolateral part of the medulla oblongata and of the rostral spinal cord exclusively in the 
area corresponding to the spinal trigeminal nucleus (TrN). These observations testify the high 
specificity of the localization of the SP in the human brain. 
Only a few authors have focused attention on the TrN in man (Rusu 2004; Dallel et al. 
2003). The structure of this nucleus, including a cellular component and a group of fibres (tract), 
is in fact difficult to identify, given its undefined boundaries. However, the TrN recognition is 
facilitated by the expression of its major neurotransmitter, the SP, in the tract. Thus, by using 
immunohistochemistry, we firstly defined the localization and traced the cytoarchitectonic 
features of this nucleus, providing essential data on its morphologic and functional 
developmental dynamics in subjects who had died of known aetiology from 17 gestational weeks 
to 10th month of life. The comparative study of the fetus and newborn coronal sections of 
medulla revealed that, while in fetuses the TrN was barely recognizable, due to limited presence 
of fibres expressing SP, a clear structural organization of this nucleus with interstitial island of 
neurons, embedded in a dense plexus of positive fibres in the tract,was evident in newborns.  
The different SP densities, varying from low in the intrauterine life to very high in the 
first postnatal months, underlines the attainment of a precise functional program in the 
coordination of the nervous system developmental steps. The SP released by neurons of the TrN 
might thus be involved in critical periods for brain plasticity and modulation of different 
autonomic vital functions. Experimental studies in rodents have showed that the TrN is involved 
in a variety of rhythmic behaviors, such as suckling, mastication, swallowing, and breathing 
(Goldberg and Chandler 1990; Lund et al. 1998). Breathing in particular is a fundamental 
mammalian activity, and must be functional at birth (Feldman et al. 2003). 
Humans usually breathe only through the nasal airway route, without using the oral 
airway route. Oral breathing along with jaw movements, aimed at maintaining upper airway 
resistance, is required under loaded respiratory conditions, such as severe hypoxia (Bartlett 
1986). Accordingly, the trigeminal respiratory activity is fundamentally involved in the network 
controlling oral breathing and plays a critical role in the regulation of upper airway patency. 
Several authors have reported that trigeminal motor activity is dramatically altered during 
respiratory disorders, such as sleep apnea (Chandler et al. 1980; Chamberlin and Saper 1998).  
In the present study we detected, in spite of what occurs in control cases, dense plexuses 
of SP immunoreactive fibres in the spinal TrN area in SIUD victims and, conversely, depletion 
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of SP-IR fibres in TrN in SIDS, frequently in the context of a hypoplasia of the whole nucleus. 
Previously, while studying the brain expression of the somatostatin, another neuropeptide 
involved in the control of respiration, we similarly have observed differential pattern of positivity 
of this neurotransmitter in the hypoglossal nucleus before and after birth in more than 50% of 
cases of sudden perinatal and infant death compared to cases with a  known etiology  of death 
(Lavezzi et al. 2004).  
The hypoglossus nucleus, even if not considered as a classic breathing center, similarly to 
the TrN, contains motoneurons with respiratory-related rhythmical discharges. In particular it 
controls the extrinsic muscles of the tongue, mainly the genioglossus that is important in 
maintaining a patent airway, especially during inspiration (Withington-Wray et al. 1988; Roda et 
al. 2002).  The TrN abnormalities, in about half the cases of this study, were associated to the 
pre-Bötzinger complex hypoplasia. This close connection is supported by experimental studies. 
Koizumi and coworkers (Koizumi et al. 2009) while working in rat brainstem-sectioning 
experiments, suggested that the origin of trigeminal respiratory activity is the pre-Bötzinger 
complex in the medulla. Their observations confirmed that trigeminal respiratory activity 
disappeared when the region corresponding to the pre-Bötzinger complex was completely 
removed. The essential role of the pre-Bötzinger complex for the generation of the respiratory 
rhythm, as well as for the modulation of eupneic breathing, has been suggested by the previous 
work of our lab (Lavezzi and Matturri 2008). In particular we reported structural and/or 
functional developmental defects (hypoplasia with a decreased neuronal number and/or dendritic 
hypodevelopment of the reticular formation, abnormal neuronal morphology, immunonegativity 
of neurotransmitters, and agenesis) of this nucleus in a high percentage of sudden fetal and infant 
deaths. Our next purpose will be to confirm, by using SP-immunohistochemistry in the recorded 
brainstem inclusions of these victims, the concomitant presence of TrN alterations. 
Discordant works have been performed with regard to the SP-IR in the brainstem of SIDS 
victims, all performed on a limited number of cases (Obonai et al. 1996; Ozawa and Takashima 
2002; Yamanouchi et al. 1993; Sawaguchi et al. 2003; Takashima et al. 1994). Only a few 
authors have observed immunopositivity in TrN. In particular, Obonai (Obonai et al. 1996) and 
Ozawa (Ozawa and Takashima 2002) reported increased expression of SP in trigeminal fibres, 
compared with age-matched controls. Conversely, in the study of Sawaguchi (Sawaguchi et al. 
1993),  no significant correlation was found between the density of SP in the TrN and SIDS.  
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Our studies and previous works reported in the literature provide insight into the 
attribution to chronic hypoxia as the cause of the neuronal abnormalities and of the pathogenetic 
mechanism of the perinatal sudden death (Matturri et al. 2002; Lavezzi et al. 2003; Kinney and 
Thach 2009; Hunt 1992). Severe hypoxia can rouse oral breathing by means of the TrN 
activation. A possible determining mechanism for hypoxic events arises from maternal cigarette 
smoking in pregnancy (Lavezzi et al. 2005; Wisborg et al. 2001). Finally, our previous 
observations of a significantly increased incidence of morphological and functional alterations in 
the brainstems of stillborns and SIDS victims with smoker mothers compared with victims with 
nonsmoker mothers (Lavezzi et al. 2005a,b; 2004;2007), prompted us to verify whether maternal 
cigarette smoking could also be related to SP abnormalities. Also in this study we observed a 
significant correlation between tobacco smoke exposure in utero and alterations of the SP 
expression in spinal TrN. 
In case of maternal smoking in pregnancy, carbon monoxide, a gaseous combustion 
product of nicotine, may readily cross the placenta by passive diffusion, where it binds to 
hemoglobin. Consequently, the carboxyhemoglobin, that is present in fetal compartment with 
concentrations generally 15% higher than maternal levels (Lambers and Clark 1996), inhibits the 
release of oxygen into fetal tissues causing hypoxia with consequent delayed maturation of all 
the organs, especially of the brain. Besides, the nicotine is one of the few lipid-soluble 
substances able to go beyond the blood-brain barrier by concentration gradient (Cutler and 
Spertell 1982; Dawson 1996), and act directly on expression of genes that control the developing 
brain. Therefore, among the numerous compounds present in cigarette smoke, carbon monoxide 
and nicotine could affect the fetal brain through indirect and/or direct action (Gressens et al. 
2003).  
Our observations of TrN alterations in some victims of non-smoking mothers could be 
attributable to the fact that many women in pregnancy are exposed to passive smoking. 
Furthermore, it should be considered that retrospective assessment of maternal smoking habit, 
mainly if performed after the fatal event, is sometimes unavoidable (Heath et al. 2003; Walsh et 
al. 1996). This may be caused by the fact that smoking mothers are reluctant to honestly report 
their tobacco use, possibly because of feelings of guilt. Besides, other risk factors, such as air 
pollution, may contribute to defects in the nervous system. Since most of the victim’s mothers 
and of infants of this study lived in large industrialized cities, we can hypothesize that also 
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atmospheric pollution may have contributed to a wrong development of the TrN. Nevertheless, 
we think that fetal nicotine exposure is one of the possible preventable factors with a strong 
potential influence on the developmental alterations of the brainstem vital centers and 
consequently on the incidence of stillbirths and infant deaths. 
Evolutinary analysis suggests that TAC1 is a new gene and is present in advanced 
animals such as vertebrates specially the mammals who have well established nervous system. It 
also shows that these genes are regulating important nervous system functions in these animals 
and not in the organisms with poorly developed nervous system. CGRP, Glutamate and VIP, 
which are found to be the colocalized and coreleased with TAC1 encoded product SP in 
trigeminal ganglion confirmed by previous studies (Lazarov 2002), is also evident from protein-
protein interaction analysis in this study.  As TAC1 is a singleton, it shows that it is a fragile 
point in the genome which means that if there is some mutation in this gene then there is no other 
gene with similar function that can compensate for its function. It can lead to deleterious effects 
and much pathology such as neuropathological and mental disorders. If the genes and nuclei 
regulating the nervous system development and cardiorespiratory control are affected, it may 
cause embryonic lethality and SIDS too because TAC1 and the interacting genes are mainly 
expressed in central nervous system.  
CONCLUSION AND OUTLOOK 
In conclusion, all pregnant women should be advised that smoking places their unborn 
children in serious danger to undergo a variety of morphological, genetic and functional 
abnormalities of the brainstem that can be cause of stillbirth and neonatal death. Moreover, the 
low success rate of smoking cessation among pregnant women, suggests that efforts to reduce 
the tobacco use in pregnancy should focus on preventing cigarette smoking among teenage girls. 
Infact, most women begin smoking early in the teenage years, and find it difficult to quit, even 
during pregnancy. Computational analysis reveals that SP encoding gene TAC1 is very 
important functionally and a mutation or alteration in this gene can lead to a fatal outcome. It 
also suggests that TAC1 is controlling many important pathways in human nervous system 
regulation. This study also suggests that trigeminal nucleus hypoplasia and SP expression 
alteration in SIDS and SIUD victims may be one of the possible mechanisms for sudden death 
pathology. 
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Apendix  
8 Abbreviations 
AHR, airway hyperresponsiveness  
AMY, amygdaloid  
ARC, Arcuate nucleus  
CD, Crohn’s disease 
CNS, central nervous system 
CRPS, complex regional pain syndrome  
C14TKL-1, chromosome 14 tachykinin-like peptide 1  
DN, Dentate nucleus 
DRG, Dorsal root ganglion 
DRN, Dorsal raphe nucleus  
EK, Endokinin 
GABA, gamma-amino butyric acid  
G-Mt, Guillain-Mollaret triangle 
GP, globus pallidus  
GPCR, G-protein coupled receptor 
HK, Hemokinin 
IBD, inflammatory bowel disease 
IBS, Irritable bowel syndrome  
IHC, Immunohistochemistry 
ILN, Intermediolateral nucleus 
ION, Inferior olivary nucleus 
IP3, inositol 1,4,5-triphosphate 
IUGR, Intra-uterine growth retardation  
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KB, Kluver-Barrera 
MC, Mast cell 
MTN, Mesencephalic Trigeminal Nucleus  
NK, Neurokinin 
NK-R, Neurokinin  Receptor 
NPK, Neuropeptide K  
NPg, Neuropeptide gamma  
nTS, nucleus tractus solitarious 
PKC, protein kinase C  
PPT, Preprotachykinin 
RN, Red nucleus 
SIDS, Sudden infant death syndrome 
SP, Substance P 
SP-IR, Substance P immunoreactivity 
SP-LI, Substance P like immunoreactivity 
SUID, Sudden unexplained infant death 
SIUD, sudden intrauterine death 
TAC, Tachykinin gene 
TACR, Tachykinin rFigure 25eceptor  gene 
TG, Trigeminal ganglion 
TK, Tachykinin 
TH, Tyrosine hydroxylase 
TNF, tumor necrosis factor  
TrN, trigeminal nucleus 
VK, Virokinin 
UC, ulcerative colitis 
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